| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.899 | 0 | 0.949 | Peptidyltransferase inhibitor | 0.949 0 DB00446 0.898 0 DBMET03152 0.909 0 DBMET03158 0.743 0.001 DBMET03161 0.727 0.001 DBMET03162 0.583 0.003 DBMET03165 0.59 0.002 DBMET03167 0.886 0.001 DBMET03169 0.895 0 DBMET03159 0.707 0.001 DBMET03163 0.726 0.001 DBMET03164 0.55 0.003 DBMET03166 0.754 0.001 DBMET03168 0.896 0 DBMET03160 | DB00446 | |
| 0.675 | 0.035 | 0.783 | Apoptosis agonist | 0.728 0.026 DB00446 0.569 0.056 DBMET03152 0.715 0.028 DBMET03158 0.291 0.179 DBMET03161 0.249 0.215 DBMET03162 0.783 0.019 DBMET03169 0.754 0.023 DBMET03159 0.292 0.178 DBMET03164 0.345 0.142 DBMET03168 0.761 0.021 DBMET03160 | DBMET03169 | |
| 0.61 | 0.018 | 0.793 | Antibacterial | 0.63 0.015 DB00446 0.7 0.009 DBMET03152 0.644 0.014 DBMET03158 0.499 0.041 DBMET03161 0.531 0.033 DBMET03162 0.493 0.043 DBMET03165 0.52 0.035 DBMET03167 0.793 0.004 DBMET03169 0.644 0.014 DBMET03159 0.539 0.031 DBMET03163 0.473 0.049 DBMET03164 0.43 0.064 DBMET03166 0.56 0.026 DBMET03168 0.617 0.017 DBMET03160 | DBMET03169 | |
| 0.467 | 0.042 | 0.574 | Calcium channel L-type activator | 0.511 0.024 DB00446 0.422 0.067 DBMET03152 0.489 0.032 DBMET03158 0.551 0.013 DBMET03161 0.536 0.016 DBMET03162 0.566 0.01 DBMET03165 0.574 0.009 DBMET03167 0.404 0.079 DBMET03169 0.441 0.056 DBMET03159 0.511 0.024 DBMET03163 0.514 0.023 DBMET03164 0.529 0.018 DBMET03166 0.549 0.013 DBMET03168 0.416 0.071 DBMET03160 | DBMET03167 | |
| 0.457 | 0.039 | 0.687 | Vasodilator, peripheral | 0.362 0.069 DB00446 0.287 0.104 DBMET03158 0.627 0.013 DBMET03161 0.616 0.014 DBMET03162 0.484 0.031 DBMET03165 0.654 0.01 DBMET03167 0.491 0.029 DBMET03169 0.425 0.048 DBMET03163 0.514 0.025 DBMET03164 0.555 0.02 DBMET03166 0.687 0.007 DBMET03168 | DBMET03168 | |
| 0.436 | 0.044 | 0.547 | Calpain 2 inhibitor | 0.411 0.055 DB00446 0.434 0.045 DBMET03158 0.523 0.018 DBMET03161 0.447 0.04 DBMET03162 0.198 0.189 DBMET03165 0.41 0.056 DBMET03167 0.348 0.088 DBMET03163 0.524 0.018 DBMET03164 0.369 0.077 DBMET03166 0.547 0.014 DBMET03168 0.344 0.09 DBMET03160 | DBMET03168 | |
| 0.425 | 0.054 | 0.526 | Immunosuppressant | 0.394 0.066 DB00446 0.353 0.085 DBMET03152 0.453 0.046 DBMET03158 0.426 0.054 DBMET03161 0.255 0.144 DBMET03162 0.323 0.101 DBMET03165 0.265 0.137 DBMET03167 0.526 0.026 DBMET03169 0.504 0.032 DBMET03159 0.33 0.098 DBMET03164 0.27 0.134 DBMET03166 0.304 0.113 DBMET03168 0.497 0.034 DBMET03160 | DBMET03169 | |
| 0.38 | 0.019 | 0.397 | Anesthetic general | 0.278 0.039 DB00446 0.394 0.017 DBMET03158 0.158 0.105 DBMET03161 0.177 0.089 DBMET03162 0.397 0.017 DBMET03165 0.302 0.033 DBMET03167 0.361 0.022 DBMET03169 0.342 0.025 DBMET03159 0.279 0.039 DBMET03166 0.219 0.064 DBMET03168 0.304 0.032 DBMET03160 | DBMET03165 | |
| 0.331 | 0.011 | 0.407 | Alkylator | 0.207 0.024 DB00446 0.228 0.02 DBMET03152 0.31 0.012 DBMET03158 0.132 0.058 DBMET03161 0.144 0.05 DBMET03162 0.173 0.035 DBMET03165 0.219 0.021 DBMET03167 0.407 0.007 DBMET03169 0.311 0.012 DBMET03159 0.175 0.035 DBMET03163 0.183 0.032 DBMET03164 0.133 0.057 DBMET03166 0.147 0.048 DBMET03168 0.329 0.011 DBMET03160 | DBMET03169 | |
| 0.36 | 0.041 | 0.504 | Interleukin 2 agonist | 0.334 0.053 DB00446 0.244 0.126 DBMET03152 0.308 0.068 DBMET03158 0.373 0.036 DBMET03161 0.396 0.029 DBMET03162 0.474 0.011 DBMET03165 0.419 0.022 DBMET03167 0.504 0.008 DBMET03169 0.297 0.076 DBMET03159 0.328 0.056 DBMET03163 0.372 0.037 DBMET03164 0.472 0.012 DBMET03166 0.404 0.026 DBMET03168 0.253 0.115 DBMET03160 | DBMET03169 | |
| 0.314 | 0.011 | 0.439 | Anesthetic local | 0.322 0.011 DB00446 0.439 0.005 DBMET03158 0.249 0.02 DBMET03161 0.202 0.032 DBMET03162 0.342 0.009 DBMET03165 0.247 0.021 DBMET03167 0.21 0.03 DBMET03159 0.103 0.08 DBMET03163 0.181 0.038 DBMET03164 0.26 0.018 DBMET03166 0.255 0.019 DBMET03168 0.279 0.015 DBMET03160 | DBMET03158 | |
| 0.358 | 0.062 | 0.528 | Immunostimulant | 0.214 0.112 DB00446 0.274 0.087 DBMET03152 0.286 0.083 DBMET03158 0.365 0.06 DBMET03161 0.399 0.05 DBMET03162 0.419 0.044 DBMET03165 0.393 0.051 DBMET03167 0.528 0.025 DBMET03169 0.29 0.082 DBMET03159 0.229 0.105 DBMET03163 0.428 0.042 DBMET03164 0.439 0.039 DBMET03166 0.418 0.045 DBMET03168 0.258 0.093 DBMET03160 | DBMET03169 | |
| 0.315 | 0.029 | 0.315 | Growth hormone agonist | 0.236 0.047 DBMET03158 0.146 0.09 DBMET03161 0.191 0.062 DBMET03162 0.215 0.053 DBMET03165 0.174 0.071 DBMET03167 0.144 0.092 DBMET03159 0.201 0.058 DBMET03164 0.24 0.046 DBMET03166 0.153 0.085 DBMET03168 0.227 0.05 DBMET03160 | ||
| 0.272 | 0.015 | 0.276 | Aldehyde dehydrogenase inhibitor | 0.196 0.029 DB00446 0.272 0.015 DBMET03158 0.117 0.074 DBMET03167 0.125 0.066 DBMET03169 0.276 0.014 DBMET03159 0.232 0.021 DBMET03160 | DBMET03159 | |
| 0.303 | 0.046 | 0.527 | Interleukin agonist | 0.249 0.08 DB00446 0.259 0.072 DBMET03158 0.394 0.02 DBMET03161 0.377 0.023 DBMET03162 0.468 0.011 DBMET03165 0.388 0.02 DBMET03167 0.439 0.014 DBMET03169 0.224 0.099 DBMET03159 0.232 0.093 DBMET03163 0.314 0.042 DBMET03164 0.527 0.007 DBMET03166 0.483 0.01 DBMET03168 0.19 0.13 DBMET03160 | DBMET03166 | |
| 0.263 | 0.038 | 0.329 | Non-steroidal antiinflammatory agent | 0.203 0.068 DB00446 0.266 0.037 DBMET03158 0.144 0.124 DBMET03162 0.208 0.065 DBMET03165 0.209 0.064 DBMET03167 0.329 0.023 DBMET03169 0.292 0.03 DBMET03159 0.147 0.119 DBMET03164 0.153 0.111 DBMET03166 0.175 0.091 DBMET03168 0.24 0.047 DBMET03160 | DBMET03169 | |
| 0.225 | 0.006 | 0.229 | Thioredoxin inhibitor | 0.199 0.008 DB00446 0.153 0.016 DBMET03152 0.221 0.006 DBMET03158 0.18 0.01 DBMET03169 0.214 0.007 DBMET03159 0.229 0.006 DBMET03160 | DBMET03160 | |
| 0.324 | 0.112 | 0.528 | Histamine release inhibitor | 0.208 0.193 DB00446 0.268 0.142 DBMET03152 0.233 0.169 DBMET03158 0.384 0.084 DBMET03161 0.487 0.033 DBMET03162 0.478 0.037 DBMET03165 0.451 0.05 DBMET03167 0.404 0.074 DBMET03169 0.452 0.049 DBMET03164 0.528 0.021 DBMET03166 0.477 0.037 DBMET03168 | DBMET03166 | |
| 0.294 | 0.081 | 0.45 | Streptokinase A inhibitor | 0.45 0.036 DB00446 0.164 0.16 DBMET03152 0.375 0.054 DBMET03158 0.331 0.068 DBMET03159 0.193 0.137 DBMET03168 0.327 0.069 DBMET03160 | DB00446 | |
| 0.263 | 0.053 | 0.33 | Calpain inhibitor | 0.249 0.066 DB00446 0.265 0.052 DBMET03158 0.309 0.027 DBMET03161 0.279 0.042 DBMET03162 0.184 0.13 DBMET03165 0.269 0.049 DBMET03167 0.172 0.145 DBMET03159 0.294 0.033 DBMET03163 0.298 0.031 DBMET03164 0.255 0.06 DBMET03166 0.33 0.021 DBMET03168 0.245 0.07 DBMET03160 | DBMET03168 | |
| 0.232 | 0.03 | 0.232 | Thiol protease inhibitor | 0.214 0.035 DB00446 0.202 0.038 DBMET03158 0.198 0.04 DBMET03161 0.174 0.052 DBMET03162 0.13 0.096 DBMET03165 0.169 0.055 DBMET03167 0.141 0.079 DBMET03159 0.125 0.106 DBMET03163 0.21 0.036 DBMET03164 0.132 0.092 DBMET03166 0.215 0.034 DBMET03168 0.166 0.056 DBMET03160 | ||
| 0.202 | 0.015 | 0.285 | Catalase inhibitor | 0.097 0.04 DB00446 0.234 0.01 DBMET03152 0.115 0.034 DBMET03158 0.219 0.012 DBMET03161 0.227 0.011 DBMET03162 0.191 0.017 DBMET03165 0.21 0.014 DBMET03167 0.102 0.038 DBMET03159 0.135 0.029 DBMET03163 0.246 0.009 DBMET03164 0.285 0.006 DBMET03166 0.206 0.014 DBMET03168 | DBMET03166 | |
| 0.282 | 0.101 | 0.534 | Antithrombotic | 0.331 0.072 DBMET03152 0.196 0.182 DBMET03158 0.273 0.109 DBMET03161 0.314 0.08 DBMET03162 0.349 0.065 DBMET03165 0.356 0.062 DBMET03167 0.534 0.025 DBMET03169 0.418 0.045 DBMET03164 0.381 0.054 DBMET03166 0.311 0.081 DBMET03168 | DBMET03169 | |
| 0.249 | 0.07 | 0.451 | Vasodilator | 0.234 0.079 DB00446 0.222 0.088 DBMET03152 0.246 0.071 DBMET03158 0.353 0.032 DBMET03161 0.327 0.04 DBMET03162 0.301 0.048 DBMET03165 0.451 0.016 DBMET03167 0.413 0.021 DBMET03169 0.157 0.148 DBMET03159 0.448 0.016 DBMET03163 0.371 0.028 DBMET03164 0.243 0.073 DBMET03166 0.404 0.022 DBMET03168 | DBMET03167 | |
| 0.278 | 0.107 | 0.498 | Vasodilator, coronary | 0.291 0.095 DB00446 0.305 0.083 DBMET03158 0.431 0.027 DBMET03161 0.404 0.034 DBMET03162 0.346 0.057 DBMET03165 0.49 0.017 DBMET03167 0.498 0.016 DBMET03169 0.194 0.187 DBMET03159 0.272 0.113 DBMET03163 0.419 0.03 DBMET03164 0.286 0.1 DBMET03166 0.466 0.021 DBMET03168 | DBMET03169 | |
| 0.218 | 0.048 | 0.268 | Growth factor agonist | 0.268 0.024 DB00446 0.212 0.053 DBMET03158 0.23 0.041 DBMET03169 0.195 0.067 DBMET03159 0.198 0.065 DBMET03160 | DB00446 | |
| 0.245 | 0.075 | 0.247 | Platelet antagonist | 0.246 0.074 DBMET03162 0.15 0.145 DBMET03169 0.247 0.074 DBMET03164 | DBMET03164 | |
| 0.16 | 0.006 | 0.256 | Protein 50S ribosomal subunit inhibitor | 0.228 0.004 DB00446 0.139 0.007 DBMET03152 0.188 0.005 DBMET03158 0.069 0.024 DBMET03161 0.069 0.025 DBMET03162 0.05 0.04 DBMET03165 0.049 0.041 DBMET03167 0.256 0.004 DBMET03169 0.179 0.005 DBMET03159 0.057 0.034 DBMET03163 0.062 0.029 DBMET03164 0.084 0.018 DBMET03168 0.18 0.005 DBMET03160 | DBMET03169 | |
| 0.169 | 0.015 | 0.342 | Triose-phosphate isomerase inhibitor | 0.161 0.017 DB00446 0.294 0.005 DBMET03152 0.136 0.025 DBMET03158 0.237 0.008 DBMET03161 0.31 0.005 DBMET03162 0.161 0.017 DBMET03165 0.342 0.004 DBMET03167 0.227 0.008 DBMET03169 0.166 0.016 DBMET03159 0.145 0.022 DBMET03163 0.209 0.01 DBMET03164 0.126 0.029 DBMET03166 0.224 0.009 DBMET03168 0.109 0.039 DBMET03160 | DBMET03167 | |
| 0.136 | 0.012 | 0.15 | Thioredoxin reductase inhibitor | 0.149 0.009 DB00446 0.106 0.024 DBMET03152 0.145 0.01 DBMET03158 0.079 0.063 DBMET03161 0.079 0.064 DBMET03162 0.088 0.044 DBMET03167 0.107 0.023 DBMET03169 0.144 0.01 DBMET03159 0.085 0.051 DBMET03168 0.15 0.009 DBMET03160 | DBMET03160 | |
| 0.137 | 0.015 | 0.239 | Glutathione S-transferase inhibitor | 0.095 0.042 DB00446 0.124 0.021 DBMET03158 0.171 0.008 DBMET03161 0.164 0.009 DBMET03162 0.078 0.065 DBMET03165 0.176 0.008 DBMET03167 0.1 0.037 DBMET03159 0.08 0.06 DBMET03163 0.239 0.004 DBMET03164 0.109 0.03 DBMET03166 0.174 0.008 DBMET03168 0.106 0.032 DBMET03160 | DBMET03164 | |
| 0.145 | 0.026 | 0.243 | NMDA receptor antagonist | 0.14 0.027 DB00446 0.191 0.016 DBMET03152 0.112 0.04 DBMET03158 0.119 0.036 DBMET03161 0.135 0.029 DBMET03162 0.177 0.018 DBMET03165 0.243 0.01 DBMET03167 0.14 0.027 DBMET03164 0.116 0.037 DBMET03166 0.117 0.037 DBMET03168 | DBMET03167 | |
| 0.137 | 0.018 | 0.157 | Glutamate dehydrogenase inhibitor | 0.067 0.062 DBMET03158 0.094 0.034 DBMET03161 0.125 0.021 DBMET03162 0.138 0.018 DBMET03165 0.157 0.015 DBMET03167 0.118 0.023 DBMET03164 0.105 0.028 DBMET03166 0.132 0.019 DBMET03168 | DBMET03167 | |
| 0.247 | 0.131 | 0.356 | Apoptosis antagonist | 0.21 0.166 DBMET03161 0.241 0.137 DBMET03162 0.21 0.166 DBMET03165 0.348 0.057 DBMET03169 0.194 0.187 DBMET03159 0.356 0.053 DBMET03164 0.194 0.188 DBMET03166 0.281 0.099 DBMET03168 | DBMET03164 | |
| 0.156 | 0.043 | 0.174 | Proteasome inhibitor | 0.147 0.048 DB00446 0.165 0.038 DBMET03158 0.159 0.041 DBMET03161 0.113 0.072 DBMET03162 0.102 0.085 DBMET03165 0.101 0.086 DBMET03167 0.148 0.048 DBMET03159 0.121 0.064 DBMET03164 0.125 0.061 DBMET03166 0.174 0.034 DBMET03168 0.161 0.04 DBMET03160 | DBMET03168 | |
| 0.218 | 0.106 | 0.279 | Tyrosine 3 hydroxylase inhibitor | 0.183 0.17 DBMET03161 0.211 0.116 DBMET03162 0.279 0.045 DBMET03165 0.268 0.052 DBMET03167 0.21 0.119 DBMET03164 0.241 0.077 DBMET03166 0.189 0.157 DBMET03168 | DBMET03165 | |
| 0.139 | 0.037 | 0.184 | Caspase 3 inhibitor | 0.112 0.072 DBMET03158 0.152 0.026 DBMET03161 0.15 0.028 DBMET03162 0.102 0.088 DBMET03167 0.106 0.082 DBMET03159 0.119 0.062 DBMET03163 0.184 0.013 DBMET03164 0.109 0.077 DBMET03166 0.172 0.016 DBMET03168 0.104 0.084 DBMET03160 | DBMET03164 | |
| 0.142 | 0.041 | 0.258 | Aminopeptidase B inhibitor | 0.134 0.045 DB00446 0.229 0.016 DBMET03152 0.123 0.051 DBMET03158 0.179 0.027 DBMET03161 0.208 0.019 DBMET03162 0.168 0.03 DBMET03165 0.221 0.017 DBMET03167 0.12 0.052 DBMET03159 0.124 0.05 DBMET03163 0.258 0.012 DBMET03164 0.15 0.038 DBMET03166 0.182 0.026 DBMET03168 0.095 0.068 DBMET03160 | DBMET03164 | |
| 0.111 | 0.014 | 0.17 | Toll-Like receptor 2 agonist | 0.045 0.026 DB00446 0.043 0.027 DBMET03158 0.13 0.012 DBMET03161 0.129 0.012 DBMET03162 0.054 0.022 DBMET03165 0.127 0.013 DBMET03167 0.042 0.028 DBMET03169 0.038 0.031 DBMET03159 0.044 0.027 DBMET03163 0.167 0.01 DBMET03164 0.09 0.015 DBMET03166 0.17 0.009 DBMET03168 | DBMET03168 | |
| 0.101 | 0.005 | 0.101 | Lysophosphatidic acid 3 receptor antagonist | 0.06 0.023 DB00446 0.07 0.015 DBMET03158 0.083 0.008 DBMET03161 0.094 0.006 DBMET03162 0.062 0.02 DBMET03165 0.069 0.015 DBMET03167 0.059 0.024 DBMET03159 0.058 0.024 DBMET03163 0.079 0.01 DBMET03164 0.061 0.021 DBMET03166 0.087 0.007 DBMET03168 0.063 0.02 DBMET03160 | ||
| 0.172 | 0.078 | 0.244 | Succinate dehydrogenase inhibitor | 0.167 0.084 DB00446 0.146 0.121 DBMET03158 0.201 0.048 DBMET03161 0.237 0.027 DBMET03162 0.199 0.05 DBMET03165 0.244 0.024 DBMET03167 0.166 0.086 DBMET03159 0.151 0.11 DBMET03163 0.189 0.058 DBMET03164 0.181 0.067 DBMET03166 0.205 0.045 DBMET03168 | DBMET03167 | |
| 0.148 | 0.056 | 0.624 | Alpha-N-acetylglucosaminidase inhibitor | 0.257 0.022 DB00446 0.195 0.035 DBMET03158 0.409 0.008 DBMET03161 0.515 0.005 DBMET03162 0.343 0.012 DBMET03165 0.27 0.02 DBMET03167 0.312 0.015 DBMET03169 0.246 0.023 DBMET03159 0.257 0.022 DBMET03163 0.362 0.011 DBMET03164 0.59 0.004 DBMET03166 0.624 0.004 DBMET03168 0.146 0.057 DBMET03160 | DBMET03168 | |
| 0.13 | 0.039 | 0.341 | Bronchodilator | 0.16 0.028 DB00446 0.091 0.073 DBMET03152 0.123 0.043 DBMET03158 0.254 0.013 DBMET03161 0.341 0.007 DBMET03162 0.34 0.007 DBMET03165 0.32 0.008 DBMET03167 0.199 0.018 DBMET03163 0.249 0.013 DBMET03164 0.24 0.014 DBMET03166 0.274 0.011 DBMET03168 | DBMET03162 | |
| 0.121 | 0.038 | 0.248 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.116 0.041 DB00446 0.087 0.07 DBMET03158 0.175 0.02 DBMET03161 0.231 0.012 DBMET03162 0.134 0.032 DBMET03165 0.248 0.01 DBMET03167 0.124 0.037 DBMET03169 0.101 0.053 DBMET03159 0.098 0.056 DBMET03163 0.136 0.031 DBMET03164 0.185 0.018 DBMET03166 0.216 0.013 DBMET03168 | DBMET03167 | |
| 0.126 | 0.044 | 0.126 | Protease inhibitor | 0.126 0.043 DB00446 0.103 0.063 DBMET03152 0.118 0.049 DBMET03158 0.098 0.068 DBMET03161 0.108 0.058 DBMET03162 0.093 0.071 DBMET03165 0.094 0.071 DBMET03169 0.111 0.056 DBMET03159 0.092 0.073 DBMET03164 0.112 0.054 DBMET03168 0.111 0.056 DBMET03160 | ||
| 0.162 | 0.08 | 0.162 | Catenin beta inhibitor | |||
| 0.107 | 0.026 | 0.272 | Glutamate decarboxylase inhibitor | 0.085 0.039 DB00446 0.074 0.051 DBMET03158 0.134 0.016 DBMET03161 0.179 0.009 DBMET03162 0.223 0.005 DBMET03165 0.272 0.004 DBMET03167 0.073 0.052 DBMET03159 0.085 0.039 DBMET03163 0.229 0.005 DBMET03164 0.148 0.013 DBMET03166 0.126 0.019 DBMET03168 | DBMET03167 | |
| 0.183 | 0.103 | 0.56 | Angiogenesis stimulant | 0.172 0.109 DB00446 0.314 0.044 DBMET03152 0.274 0.06 DBMET03161 0.274 0.059 DBMET03162 0.353 0.032 DBMET03165 0.312 0.045 DBMET03167 0.56 0.009 DBMET03169 0.167 0.112 DBMET03159 0.211 0.089 DBMET03163 0.313 0.044 DBMET03164 0.295 0.051 DBMET03166 0.293 0.052 DBMET03168 | DBMET03169 | |
| 0.15 | 0.074 | 0.186 | Phospholipase A2 inhibitor | 0.128 0.103 DBMET03161 0.174 0.057 DBMET03162 0.138 0.089 DBMET03165 0.149 0.075 DBMET03167 0.186 0.05 DBMET03164 0.137 0.089 DBMET03166 0.144 0.08 DBMET03168 | DBMET03164 | |
| 0.119 | 0.045 | 0.169 | Carbonic anhydrase III inhibitor | 0.103 0.059 DBMET03161 0.112 0.051 DBMET03162 0.169 0.023 DBMET03165 0.167 0.023 DBMET03167 0.109 0.053 DBMET03164 0.141 0.032 DBMET03166 0.149 0.029 DBMET03168 | DBMET03165 | |
| 0.093 | 0.022 | 0.139 | GABA B receptor agonist | 0.077 0.049 DB00446 0.118 0.008 DBMET03161 0.114 0.009 DBMET03162 0.095 0.02 DBMET03165 0.139 0.005 DBMET03167 0.099 0.017 DBMET03164 0.089 0.026 DBMET03166 0.1 0.017 DBMET03168 | DBMET03167 | |
| 0.115 | 0.045 | 0.201 | Factor V inhibitor | 0.109 0.053 DB00446 0.104 0.06 DBMET03158 0.129 0.031 DBMET03161 0.201 0.005 DBMET03162 0.092 0.091 DBMET03165 0.119 0.04 DBMET03167 0.104 0.06 DBMET03159 0.107 0.055 DBMET03163 0.13 0.03 DBMET03164 0.094 0.084 DBMET03166 0.119 0.04 DBMET03168 0.103 0.062 DBMET03160 | DBMET03162 | |
| 0.088 | 0.025 | 0.229 | NMDA receptor agonist | 0.072 0.034 DB00446 0.205 0.004 DBMET03152 0.076 0.032 DBMET03158 0.112 0.015 DBMET03161 0.154 0.008 DBMET03162 0.179 0.005 DBMET03165 0.198 0.005 DBMET03167 0.075 0.032 DBMET03159 0.057 0.052 DBMET03163 0.16 0.007 DBMET03164 0.229 0.004 DBMET03166 0.162 0.007 DBMET03168 | DBMET03166 | |
| 0.222 | 0.159 | 0.425 | Sodium/bile acid cotransporter inhibitor | 0.257 0.121 DBMET03162 0.425 0.011 DBMET03164 | DBMET03164 | |
| 0.113 | 0.051 | 0.276 | Adenylate kinase inhibitor | 0.098 0.071 DB00446 0.092 0.083 DBMET03158 0.14 0.03 DBMET03161 0.172 0.02 DBMET03162 0.191 0.016 DBMET03165 0.276 0.008 DBMET03167 0.092 0.083 DBMET03159 0.098 0.071 DBMET03163 0.194 0.016 DBMET03164 0.118 0.045 DBMET03166 0.143 0.029 DBMET03168 | DBMET03167 | |
| 0.11 | 0.055 | 0.178 | Toll-Like receptor 4 antagonist | 0.102 0.067 DBMET03158 0.101 0.069 DBMET03161 0.118 0.046 DBMET03162 0.092 0.085 DBMET03165 0.124 0.04 DBMET03167 0.178 0.01 DBMET03169 0.097 0.075 DBMET03159 0.108 0.058 DBMET03164 0.111 0.054 DBMET03168 0.091 0.088 DBMET03160 | DBMET03169 | |
| 0.079 | 0.024 | 0.084 | Caspase 9 inhibitor | 0.057 0.055 DBMET03158 0.063 0.041 DBMET03161 0.069 0.033 DBMET03162 0.066 0.036 DBMET03163 0.084 0.021 DBMET03164 0.063 0.041 DBMET03168 | DBMET03164 | |
| 0.183 | 0.13 | 0.404 | Hypoglycemic | 0.213 0.101 DBMET03161 0.255 0.074 DBMET03162 0.256 0.073 DBMET03165 0.214 0.1 DBMET03167 0.404 0.027 DBMET03169 0.171 0.146 DBMET03163 0.358 0.036 DBMET03164 0.185 0.128 DBMET03166 0.242 0.082 DBMET03168 | DBMET03169 | |
| 0.106 | 0.053 | 0.261 | Sphingomyelinase inhibitor | 0.165 0.019 DB00446 0.131 0.034 DBMET03158 0.218 0.007 DBMET03161 0.184 0.013 DBMET03162 0.195 0.01 DBMET03165 0.18 0.014 DBMET03167 0.098 0.062 DBMET03169 0.126 0.037 DBMET03159 0.242 0.005 DBMET03163 0.166 0.018 DBMET03164 0.179 0.014 DBMET03166 0.261 0.004 DBMET03168 0.126 0.037 DBMET03160 | DBMET03168 | |
| 0.096 | 0.046 | 0.167 | Interleukin 5 antagonist | 0.11 0.032 DB00446 0.102 0.039 DBMET03158 0.135 0.016 DBMET03161 0.131 0.017 DBMET03162 0.119 0.024 DBMET03165 0.167 0.008 DBMET03167 0.093 0.05 DBMET03159 0.1 0.041 DBMET03163 0.124 0.021 DBMET03164 0.109 0.032 DBMET03166 0.14 0.014 DBMET03168 0.079 0.076 DBMET03160 | DBMET03167 | |
| 0.179 | 0.131 | 0.356 | Nitric-oxide synthase stimulant | 0.254 0.03 DB00446 0.248 0.034 DBMET03158 0.298 0.012 DBMET03161 0.278 0.018 DBMET03162 0.274 0.02 DBMET03165 0.356 0.005 DBMET03167 0.231 0.048 DBMET03169 0.221 0.059 DBMET03159 0.234 0.045 DBMET03163 0.254 0.03 DBMET03164 0.242 0.038 DBMET03166 0.298 0.012 DBMET03168 0.22 0.06 DBMET03160 | DBMET03167 | |
| 0.073 | 0.029 | 0.09 | Nitric oxide donor | 0.071 0.031 DBMET03158 0.081 0.021 DBMET03161 0.09 0.014 DBMET03162 0.075 0.027 DBMET03167 0.063 0.043 DBMET03169 0.064 0.042 DBMET03159 0.071 0.032 DBMET03163 0.078 0.024 DBMET03164 0.073 0.029 DBMET03168 0.076 0.026 DBMET03160 | DBMET03162 | |
| 0.186 | 0.144 | 0.344 | DNA synthesis inhibitor | 0.192 0.136 DBMET03158 0.214 0.102 DBMET03161 0.225 0.088 DBMET03162 0.344 0.032 DBMET03165 0.304 0.042 DBMET03167 0.216 0.1 DBMET03169 0.198 0.127 DBMET03159 0.236 0.077 DBMET03164 0.234 0.079 DBMET03166 0.239 0.074 DBMET03168 0.174 0.163 DBMET03160 | DBMET03165 | |
| 0.126 | 0.091 | 0.285 | Cell wall synthesis inhibitor | 0.119 0.101 DB00446 0.25 0.016 DBMET03152 0.145 0.071 DBMET03158 0.192 0.033 DBMET03161 0.249 0.016 DBMET03162 0.227 0.021 DBMET03165 0.274 0.012 DBMET03167 0.193 0.033 DBMET03169 0.136 0.079 DBMET03159 0.285 0.011 DBMET03163 0.222 0.023 DBMET03164 0.234 0.019 DBMET03166 0.246 0.017 DBMET03168 0.113 0.111 DBMET03160 | DBMET03163 | |
| 0.099 | 0.066 | 0.242 | Folate antagonist | 0.242 0.005 DBMET03163 | DBMET03163 | |
| 0.118 | 0.088 | 0.223 | Interleukin 4 antagonist | 0.125 0.079 DB00446 0.138 0.062 DBMET03158 0.166 0.037 DBMET03161 0.168 0.036 DBMET03162 0.151 0.049 DBMET03165 0.223 0.017 DBMET03167 0.152 0.048 DBMET03169 0.192 0.025 DBMET03159 0.115 0.093 DBMET03163 0.14 0.06 DBMET03164 0.187 0.027 DBMET03166 0.183 0.029 DBMET03168 0.167 0.037 DBMET03160 | DBMET03167 | |
| 0.195 | 0.169 | 0.307 | Cholesterol antagonist | 0.268 0.113 DBMET03162 0.307 0.087 DBMET03165 0.246 0.128 DBMET03167 0.277 0.107 DBMET03169 0.208 0.158 DBMET03164 0.23 0.14 DBMET03166 | DBMET03165 | |
| 0.062 | 0.038 | 0.076 | Carbonic anhydrase stimulant | 0.053 0.05 DB00446 0.076 0.028 DBMET03165 0.053 0.049 DBMET03164 0.074 0.029 DBMET03166 | DBMET03165 | |
| 0.042 | 0.02 | 0.096 | Glutamate (mGluR8) agonist | 0.045 0.016 DBMET03161 0.055 0.009 DBMET03162 0.072 0.005 DBMET03165 0.096 0.003 DBMET03167 0.04 0.023 DBMET03164 0.047 0.014 DBMET03166 0.045 0.015 DBMET03168 | DBMET03167 | |
| 0.033 | 0.012 | 0.079 | Protein 30S ribosomal subunit inhibitor | 0.059 0.006 DB00446 0.028 0.014 DBMET03152 0.04 0.01 DBMET03158 0.025 0.016 DBMET03161 0.022 0.019 DBMET03165 0.079 0.004 DBMET03169 0.033 0.012 DBMET03159 0.025 0.016 DBMET03163 0.024 0.016 DBMET03168 0.029 0.013 DBMET03160 | DBMET03169 | |
| 0.083 | 0.064 | 0.117 | Transcription factor NF kappa B stimulant | 0.08 0.069 DBMET03162 0.083 0.064 DBMET03165 0.078 0.074 DBMET03167 0.117 0.027 DBMET03169 0.078 0.074 DBMET03164 0.081 0.067 DBMET03166 0.081 0.068 DBMET03168 | DBMET03169 | |
| 0.043 | 0.026 | 0.051 | Cathepsin F inhibitor | 0.051 0.012 DB00446 0.042 0.028 DBMET03152 0.045 0.021 DBMET03158 0.04 0.033 DBMET03169 0.043 0.024 DBMET03159 0.045 0.02 DBMET03160 | DB00446 | |
| 0.117 | 0.1 | 0.162 | Neurotrophic factor | 0.159 0.052 DB00446 0.118 0.099 DBMET03161 0.162 0.05 DBMET03165 0.122 0.091 DBMET03167 0.14 0.069 DBMET03169 0.119 0.096 DBMET03159 0.144 0.064 DBMET03166 0.118 0.099 DBMET03168 | DBMET03165 | |
| 0.035 | 0.019 | 0.047 | Caspase 2 inhibitor | 0.03 0.023 DBMET03162 0.032 0.022 DBMET03159 0.03 0.023 DBMET03166 0.047 0.013 DBMET03168 0.032 0.022 DBMET03160 | DBMET03168 | |
| 0.059 | 0.047 | 0.346 | NMDA 2C receptor antagonist | 0.077 0.027 DB00446 0.127 0.009 DBMET03161 0.14 0.008 DBMET03162 0.221 0.005 DBMET03165 0.346 0.004 DBMET03167 0.063 0.041 DBMET03163 0.172 0.005 DBMET03164 0.124 0.01 DBMET03166 0.137 0.008 DBMET03168 | DBMET03167 | |
| 0.046 | 0.034 | 0.215 | Glycine transporter 2 inhibitor | 0.062 0.024 DBMET03161 0.086 0.016 DBMET03162 0.093 0.014 DBMET03167 0.215 0.005 DBMET03164 0.041 0.038 DBMET03166 0.071 0.02 DBMET03168 | DBMET03164 | |
| 0.106 | 0.095 | 0.252 | Cyclooxygenase 3 inhibitor | 0.144 0.054 DBMET03158 0.113 0.085 DBMET03161 0.138 0.059 DBMET03162 0.19 0.022 DBMET03165 0.14 0.057 DBMET03167 0.167 0.035 DBMET03169 0.139 0.058 DBMET03159 0.123 0.074 DBMET03164 0.252 0.009 DBMET03166 0.175 0.03 DBMET03168 0.146 0.052 DBMET03160 | DBMET03166 | |
| 0.043 | 0.033 | 0.048 | AICAR transformylase inhibitor | 0.048 0.024 DBMET03162 0.044 0.031 DBMET03164 0.04 0.038 DBMET03168 | DBMET03162 | |
| 0.147 | 0.138 | 0.248 | Insulin sensitizer | 0.153 0.129 DBMET03161 0.192 0.081 DBMET03162 0.248 0.036 DBMET03165 0.203 0.071 DBMET03167 0.224 0.052 DBMET03164 0.238 0.041 DBMET03166 0.206 0.067 DBMET03168 | DBMET03165 | |
| 0.027 | 0.02 | 0.039 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.039 0.013 DB00446 0.031 0.017 DBMET03165 0.031 0.017 DBMET03167 0.026 0.021 DBMET03164 | DB00446 | |
| 0.086 | 0.08 | 0.086 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.051 | 0.046 | 0.054 | Cathepsin B inhibitor | 0.052 0.045 DBMET03158 0.054 0.042 DBMET03168 | DBMET03168 | |
| 0.024 | 0.02 | 0.034 | Lysophosphatidic acid receptor 1 agonist | 0.03 0.011 DBMET03161 0.034 0.008 DBMET03162 0.031 0.01 DBMET03165 0.026 0.016 DBMET03167 0.034 0.008 DBMET03164 0.031 0.01 DBMET03166 0.033 0.009 DBMET03168 | DBMET03164 | |
| 0.06 | 0.057 | 0.175 | Phosphofructokinase-1 inhibitor | 0.078 0.042 DBMET03161 0.11 0.028 DBMET03162 0.152 0.018 DBMET03165 0.175 0.014 DBMET03167 0.082 0.04 DBMET03169 0.076 0.044 DBMET03164 0.068 0.05 DBMET03166 0.067 0.05 DBMET03168 | DBMET03167 | |
| 0.015 | 0.012 | 0.016 | Thromboxane A2 agonist | 0.016 0.01 DBMET03162 0.014 0.013 DBMET03167 | DBMET03162 | |
| 0.028 | 0.026 | 0.028 | Prostaglandin D2 agonist | |||
| 0.059 | 0.058 | 0.123 | Beta adrenoreceptor antagonist | 0.062 0.052 DB00446 0.06 0.056 DBMET03158 0.114 0.012 DBMET03161 0.085 0.024 DBMET03162 0.109 0.013 DBMET03165 0.11 0.013 DBMET03167 0.079 0.027 DBMET03163 0.12 0.01 DBMET03164 0.114 0.012 DBMET03166 0.123 0.009 DBMET03168 | DBMET03168 | |
| 0.096 | 0.097 | 0.114 | Photosensitizer | 0.098 0.092 DBMET03162 0.114 0.065 DBMET03165 0.11 0.072 DBMET03167 0.114 0.066 DBMET03168 | DBMET03168 | |
| 0.045 | 0.049 | 0.073 | CD45 antagonist | 0.049 0.037 DBMET03161 0.049 0.036 DBMET03162 0.073 0.014 DBMET03164 0.051 0.033 DBMET03168 | DBMET03164 | |
| 0.131 | 0.135 | 0.478 | Psychostimulant | 0.199 0.081 DBMET03161 0.172 0.098 DBMET03162 0.478 0.013 DBMET03165 0.335 0.034 DBMET03167 0.151 0.115 DBMET03164 0.341 0.033 DBMET03166 0.299 0.043 DBMET03168 | DBMET03165 | |
| 0.05 | 0.055 | 0.136 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.048 DBMET03161 0.058 0.033 DBMET03162 0.107 0.008 DBMET03165 0.117 0.006 DBMET03167 0.071 0.018 DBMET03164 0.136 0.005 DBMET03166 0.056 0.037 DBMET03168 | DBMET03166 | |
| 0.027 | 0.034 | 0.049 | Catechol O-methyltransferase inhibitor | 0.035 0.019 DBMET03161 0.034 0.02 DBMET03162 0.049 0.009 DBMET03167 0.03 0.028 DBMET03164 0.034 0.02 DBMET03168 | DBMET03167 | |
| 0.089 | 0.096 | 0.131 | Nav1.4 sodium channel blocker | 0.105 0.069 DBMET03152 0.096 0.083 DBMET03162 0.131 0.044 DBMET03165 0.123 0.05 DBMET03167 0.126 0.047 DBMET03166 0.097 0.08 DBMET03168 | DBMET03165 | |
| 0.075 | 0.085 | 0.12 | 3C-Like protease (SARS coronavirus) inhibitor | 0.083 0.06 DB00446 0.078 0.074 DBMET03158 0.102 0.031 DBMET03161 0.093 0.042 DBMET03162 0.082 0.064 DBMET03167 0.083 0.061 DBMET03159 0.08 0.069 DBMET03163 0.088 0.051 DBMET03164 0.12 0.019 DBMET03168 0.079 0.073 DBMET03160 | DBMET03168 | |
| 0.029 | 0.041 | 0.051 | Ceramide glucosyltransferase inhibitor | 0.039 0.019 DBMET03152 0.043 0.013 DBMET03161 0.037 0.022 DBMET03162 0.051 0.006 DBMET03165 0.04 0.018 DBMET03167 0.035 0.026 DBMET03169 0.036 0.023 DBMET03164 0.038 0.02 DBMET03166 0.041 0.015 DBMET03168 | DBMET03165 | |
| 0.037 | 0.049 | 0.078 | Glutamate (mGluR4) antagonist | 0.042 0.032 DBMET03162 0.078 0.009 DBMET03167 | DBMET03167 | |
| 0.042 | 0.055 | 0.086 | Maillard reaction inhibitor | 0.054 0.04 DBMET03162 0.085 0.023 DBMET03165 0.086 0.022 DBMET03167 0.053 0.04 DBMET03166 0.059 0.035 DBMET03168 | DBMET03167 | |
| 0.056 | 0.069 | 0.271 | Histidine decarboxylase inhibitor | 0.109 0.028 DBMET03161 0.17 0.016 DBMET03162 0.156 0.018 DBMET03165 0.271 0.008 DBMET03167 0.25 0.009 DBMET03164 0.072 0.048 DBMET03166 0.098 0.032 DBMET03168 | DBMET03167 | |
| 0.03 | 0.044 | 0.04 | Integrin alpha2 antagonist | 0.04 0.021 DBMET03162 | DBMET03162 | |
| 0.041 | 0.055 | 0.053 | Collagenase inhibitor | 0.046 0.042 DBMET03161 0.047 0.04 DBMET03162 0.053 0.026 DBMET03164 0.049 0.036 DBMET03168 | DBMET03164 | |
| 0.075 | 0.09 | 0.105 | Hematopoietic | 0.08 0.072 DBMET03161 0.087 0.055 DBMET03162 0.104 0.032 DBMET03165 0.089 0.05 DBMET03167 0.105 0.031 DBMET03164 0.105 0.031 DBMET03166 0.094 0.043 DBMET03168 | DBMET03166 | |
| 0.025 | 0.04 | 0.043 | Caspase 6 inhibitor | 0.037 0.01 DBMET03163 0.043 0.006 DBMET03164 | DBMET03164 | |
| 0.038 | 0.053 | 0.228 | Ornithine carbamoyltransferase inhibitor | 0.065 0.028 DB00446 0.104 0.015 DBMET03161 0.141 0.01 DBMET03162 0.136 0.011 DBMET03165 0.228 0.006 DBMET03167 0.056 0.034 DBMET03159 0.065 0.028 DBMET03163 0.173 0.008 DBMET03164 0.085 0.02 DBMET03166 0.103 0.015 DBMET03168 | DBMET03167 | |
| 0.096 | 0.112 | 0.186 | Toll-Like receptor 2 antagonist | 0.104 0.099 DBMET03161 0.103 0.099 DBMET03162 0.142 0.058 DBMET03165 0.105 0.097 DBMET03167 0.106 0.096 DBMET03164 0.186 0.03 DBMET03166 0.124 0.073 DBMET03168 | DBMET03166 | |
| 0.007 | 0.023 | 0.026 | Glutamate (mGluR6) agonist | 0.011 0.01 DBMET03162 0.013 0.008 DBMET03165 0.026 0.003 DBMET03167 | DBMET03167 | |
| 0.035 | 0.052 | 0.039 | VCAM-1 antagonist | 0.038 0.033 DBMET03162 0.039 0.031 DBMET03164 | DBMET03164 | |
| 0.034 | 0.052 | 0.038 | VCAM antagonist | 0.038 0.033 DBMET03162 0.038 0.031 DBMET03164 | DBMET03164 | |
| 0.116 | 0.134 | 0.23 | Adenylate cyclase stimulant | 0.138 0.085 DBMET03161 0.146 0.07 DBMET03162 0.23 0.005 DBMET03165 0.17 0.035 DBMET03167 0.139 0.083 DBMET03164 0.168 0.038 DBMET03166 0.139 0.082 DBMET03168 | DBMET03165 | |
| 0.014 | 0.032 | 0.019 | Corticosteroid-like | 0.019 0.018 DBMET03169 | DBMET03169 | |
| 0.085 | 0.103 | 0.221 | Mucolytic | 0.1 0.077 DBMET03161 0.127 0.049 DBMET03162 0.191 0.016 DBMET03165 0.129 0.047 DBMET03167 0.172 0.022 DBMET03164 0.221 0.01 DBMET03166 0.159 0.028 DBMET03168 | DBMET03166 | |
| 0.034 | 0.052 | 0.148 | Mannosidase inhibitor | 0.048 0.027 DB00446 0.103 0.005 DBMET03152 0.075 0.01 DBMET03161 0.081 0.009 DBMET03162 0.101 0.005 DBMET03165 0.148 0.004 DBMET03167 0.109 0.005 DBMET03169 0.048 0.028 DBMET03163 0.083 0.008 DBMET03164 0.077 0.009 DBMET03166 0.075 0.01 DBMET03168 | DBMET03167 | |
| 0.007 | 0.027 | 0.016 | Lysophosphatidic acid receptor 3 agonist | 0.016 0.007 DBMET03165 0.012 0.011 DBMET03167 0.013 0.01 DBMET03166 0.013 0.01 DBMET03168 | DBMET03165 | |
| 0.04 | 0.061 | 0.074 | Aminopeptidase microsomal inhibitor | 0.049 0.048 DBMET03162 0.074 0.029 DBMET03165 0.068 0.033 DBMET03167 0.062 0.038 DBMET03164 0.055 0.043 DBMET03166 | DBMET03165 | |
| 0.03 | 0.052 | 0.154 | Phosphorylase inhibitor | 0.04 0.037 DBMET03152 0.062 0.024 DBMET03161 0.123 0.01 DBMET03162 0.075 0.018 DBMET03165 0.072 0.019 DBMET03167 0.056 0.027 DBMET03169 0.154 0.007 DBMET03164 0.053 0.028 DBMET03166 0.062 0.024 DBMET03168 | DBMET03164 | |
| 0.044 | 0.066 | 0.173 | Carbamoyl phosphate synthetase inhibitor | 0.068 0.036 DBMET03162 0.173 0.009 DBMET03165 0.119 0.016 DBMET03167 0.09 0.024 DBMET03166 | DBMET03165 | |
| 0.053 | 0.075 | 0.208 | Neuraminidase (influenza) inhibitor | 0.059 0.057 DB00446 0.067 0.039 DBMET03152 0.087 0.021 DBMET03161 0.076 0.028 DBMET03162 0.11 0.014 DBMET03165 0.115 0.013 DBMET03167 0.086 0.022 DBMET03169 0.076 0.029 DBMET03163 0.098 0.017 DBMET03164 0.208 0.004 DBMET03166 0.175 0.005 DBMET03168 | DBMET03166 | |
| 0.043 | 0.066 | 0.139 | Biliverdin reductase inhibitor | 0.083 0.025 DBMET03161 0.112 0.015 DBMET03162 0.09 0.022 DBMET03165 0.139 0.011 DBMET03167 0.069 0.033 DBMET03164 0.057 0.044 DBMET03166 0.08 0.026 DBMET03168 | DBMET03167 | |
| 0.064 | 0.087 | 0.077 | Chymotrypsin inhibitor | 0.073 0.065 DBMET03152 0.074 0.062 DBMET03164 0.077 0.058 DBMET03168 | DBMET03168 | |
| 0.019 | 0.042 | 0.054 | NMDA 2D receptor antagonist | 0.054 0.006 DBMET03152 0.028 0.018 DBMET03161 0.03 0.016 DBMET03162 0.042 0.009 DBMET03167 0.026 0.021 DBMET03164 0.026 0.021 DBMET03168 | DBMET03152 | |
| 0.105 | 0.129 | 0.259 | Thrombolytic | 0.178 0.063 DBMET03161 0.214 0.045 DBMET03162 0.163 0.072 DBMET03165 0.174 0.066 DBMET03167 0.172 0.066 DBMET03169 0.259 0.031 DBMET03164 0.143 0.087 DBMET03166 0.143 0.087 DBMET03168 | DBMET03164 | |
| 0.048 | 0.072 | 0.157 | Sphingosine 1-phosphate receptor 4 agonist | 0.069 0.045 DBMET03161 0.096 0.027 DBMET03162 0.099 0.025 DBMET03165 0.157 0.007 DBMET03167 0.125 0.015 DBMET03164 0.072 0.043 DBMET03168 | DBMET03167 | |
| 0.089 | 0.113 | 0.119 | Microtubule formation inhibitor | 0.112 0.071 DBMET03158 0.119 0.062 DBMET03165 0.117 0.064 DBMET03169 0.117 0.064 DBMET03159 0.108 0.076 DBMET03160 | DBMET03165 | |
| 0.065 | 0.091 | 0.149 | Sphingosine 1-phosphate receptor antagonist | 0.072 0.065 DBMET03161 0.077 0.051 DBMET03162 0.112 0.015 DBMET03165 0.139 0.008 DBMET03167 0.087 0.034 DBMET03164 0.149 0.006 DBMET03166 0.081 0.044 DBMET03168 | DBMET03166 | |
| 0.011 | 0.037 | 0.028 | Human T-cell leukemia virus type I protease inhibitor | 0.019 0.017 DBMET03161 0.028 0.009 DBMET03168 | DBMET03168 | |
| 0.046 | 0.074 | 0.064 | Cathepsin E inhibitor | 0.061 0.039 DBMET03161 0.055 0.05 DBMET03162 0.064 0.035 DBMET03168 | DBMET03168 | |
| 0.053 | 0.083 | 0.068 | Cathepsin G inhibitor | 0.068 0.056 DBMET03162 0.067 0.058 DBMET03165 0.068 0.056 DBMET03167 0.065 0.06 DBMET03168 | DBMET03167 | |
| 0.008 | 0.038 | 0.045 | Ileal bile acid transport inhibitor | 0.025 0.006 DBMET03161 0.045 0.004 DBMET03162 0.036 0.004 DBMET03165 0.016 0.013 DBMET03167 0.041 0.004 DBMET03164 0.028 0.005 DBMET03166 0.019 0.01 DBMET03168 | DBMET03162 | |
| 0.014 | 0.045 | 0.038 | Cholecystokinin B antagonist | 0.038 0.015 DBMET03152 0.028 0.024 DBMET03164 | DBMET03152 | |
| 0.047 | 0.078 | 0.06 | CDC25B inhibitor | 0.059 0.052 DBMET03162 0.058 0.054 DBMET03165 0.06 0.051 DBMET03168 | DBMET03168 | |
| 0.038 | 0.069 | 0.093 | Beta 1 adrenoreceptor antagonist | 0.079 0.018 DBMET03161 0.065 0.031 DBMET03162 0.088 0.014 DBMET03165 0.085 0.015 DBMET03167 0.072 0.024 DBMET03164 0.091 0.013 DBMET03166 0.093 0.012 DBMET03168 | DBMET03168 | |
| 0.021 | 0.052 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.008 DBMET03169 | DBMET03169 | |
| 0.019 | 0.05 | 0.056 | Cholecystokinin antagonist | 0.056 0.021 DBMET03152 0.038 0.03 DBMET03162 0.043 0.028 DBMET03164 | DBMET03152 | |
| 0.031 | 0.064 | 0.127 | Neuropeptide agonist | 0.063 0.037 DB00446 0.116 0.023 DBMET03161 0.075 0.033 DBMET03162 0.125 0.021 DBMET03165 0.122 0.022 DBMET03167 0.058 0.039 DBMET03163 0.066 0.036 DBMET03164 0.116 0.023 DBMET03166 0.127 0.02 DBMET03168 | DBMET03168 | |
| 0.051 | 0.084 | 0.08 | Carbonic anhydrase XIII inhibitor | 0.08 0.05 DBMET03165 | DBMET03165 | |
| 0.018 | 0.052 | 0.063 | Cholecystokinin A antagonist | 0.063 0.016 DBMET03152 | DBMET03152 | |
| 0.091 | 0.127 | 0.224 | Cathepsin H inhibitor | 0.132 0.062 DB00446 0.176 0.031 DBMET03161 0.175 0.031 DBMET03162 0.17 0.034 DBMET03165 0.205 0.021 DBMET03167 0.107 0.094 DBMET03159 0.119 0.076 DBMET03163 0.157 0.041 DBMET03164 0.129 0.065 DBMET03166 0.224 0.017 DBMET03168 | DBMET03168 | |
| 0.118 | 0.155 | 0.412 | Interleukin antagonist | 0.252 0.061 DBMET03161 0.184 0.094 DBMET03162 0.244 0.064 DBMET03165 0.229 0.07 DBMET03167 0.262 0.057 DBMET03164 0.328 0.042 DBMET03166 0.412 0.029 DBMET03168 | DBMET03168 | |
| 0.026 | 0.064 | 0.049 | Aminopeptidase N inhibitor | 0.049 0.032 DBMET03165 0.045 0.036 DBMET03167 0.041 0.04 DBMET03164 | DBMET03165 | |
| 0.038 | 0.076 | 0.133 | Alpha-mannosidase inhibitor | 0.059 0.029 DB00446 0.105 0.006 DBMET03152 0.082 0.01 DBMET03161 0.087 0.009 DBMET03162 0.101 0.006 DBMET03165 0.133 0.004 DBMET03167 0.103 0.006 DBMET03169 0.058 0.029 DBMET03163 0.09 0.008 DBMET03164 0.083 0.01 DBMET03166 0.084 0.01 DBMET03168 | DBMET03167 | |
| 0.036 | 0.074 | 0.157 | Argininosuccinate synthase inhibitor | 0.053 0.043 DBMET03161 0.076 0.027 DBMET03162 0.114 0.016 DBMET03165 0.157 0.011 DBMET03167 0.05 0.047 DBMET03164 0.059 0.038 DBMET03166 0.058 0.039 DBMET03168 | DBMET03167 | |
| 0.009 | 0.049 | 0.018 | Kainate receptor 3 antagonist | 0.018 0.011 DBMET03167 | DBMET03167 | |
| 0.041 | 0.082 | 0.05 | Angiotensin-converting enzyme inhibitor | 0.05 0.047 DBMET03164 | DBMET03164 | |
| 0.018 | 0.06 | 0.043 | Acid ceramidase inhibitor | 0.03 0.009 DB00446 0.042 0.004 DBMET03161 0.032 0.007 DBMET03162 0.032 0.007 DBMET03167 0.028 0.012 DBMET03163 0.029 0.01 DBMET03164 0.043 0.004 DBMET03168 0.026 0.017 DBMET03160 | DBMET03168 | |
| 0.028 | 0.071 | 0.06 | Thymidylate synthase inhibitor | 0.053 0.024 DBMET03162 0.044 0.036 DBMET03167 0.06 0.017 DBMET03164 | DBMET03164 | |
| 0.058 | 0.102 | 0.096 | Carbonic anhydrase VI inhibitor | 0.096 0.042 DBMET03165 | DBMET03165 | |
| 0.025 | 0.072 | 0.156 | NMDA 2A receptor antagonist | 0.064 0.027 DBMET03161 0.077 0.021 DBMET03162 0.146 0.007 DBMET03165 0.156 0.007 DBMET03167 0.134 0.008 DBMET03164 0.072 0.023 DBMET03166 0.069 0.025 DBMET03168 | DBMET03167 | |
| 0.036 | 0.083 | 0.186 | Neuraminidase inhibitor | 0.08 0.026 DBMET03161 0.069 0.034 DBMET03162 0.098 0.016 DBMET03165 0.096 0.017 DBMET03167 0.074 0.03 DBMET03169 0.064 0.039 DBMET03163 0.085 0.022 DBMET03164 0.186 0.004 DBMET03166 0.153 0.005 DBMET03168 | DBMET03166 | |
| 0.018 | 0.065 | 0.037 | Fumarate hydratase inhibitor | 0.037 0.021 DBMET03165 0.035 0.023 DBMET03167 | DBMET03165 | |
| 0.023 | 0.073 | 0.142 | Cholecystokinin B agonist | 0.142 0.005 DBMET03152 | DBMET03152 | |
| 0.018 | 0.068 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.014 DBMET03152 0.034 0.008 DBMET03165 0.031 0.013 DBMET03167 0.03 0.017 DBMET03169 0.031 0.014 DBMET03166 0.027 0.024 DBMET03168 | DBMET03165 | |
| 0.018 | 0.068 | 0.029 | Lysophosphatidic acid 2 receptor antagonist | 0.029 0.023 DBMET03165 | DBMET03165 | |
| 0.021 | 0.073 | 0.029 | Elastase 3A inhibitor | 0.029 0.026 DBMET03160 | DBMET03160 | |
| 0.021 | 0.073 | 0.029 | Elastase 3B inhibitor | 0.029 0.026 DBMET03160 | DBMET03160 | |
| 0.021 | 0.073 | 0.029 | Elastase 2B inhibitor | 0.029 0.026 DBMET03160 | DBMET03160 | |
| 0.037 | 0.089 | 0.068 | Androgen agonist | 0.067 0.033 DB00446 0.055 0.048 DBMET03152 0.062 0.039 DBMET03158 0.064 0.037 DBMET03161 0.059 0.042 DBMET03167 0.068 0.032 DBMET03159 0.054 0.051 DBMET03168 0.059 0.043 DBMET03160 | DBMET03159 | |
| 0.042 | 0.095 | 0.479 | Phenylalanine 4-hydroxylase inhibitor | 0.061 0.057 DB00446 0.108 0.022 DBMET03161 0.146 0.012 DBMET03162 0.479 0.003 DBMET03165 0.306 0.004 DBMET03167 0.148 0.012 DBMET03164 0.326 0.004 DBMET03166 0.13 0.015 DBMET03168 | DBMET03165 | |
| 0.032 | 0.086 | 0.05 | Human rhinovirus A protease inhibitor | 0.05 0.043 DBMET03168 | DBMET03168 | |
| 0.047 | 0.102 | 0.121 | Aminopeptidase I inhibitor | 0.077 0.045 DBMET03161 0.096 0.03 DBMET03162 0.121 0.019 DBMET03165 0.102 0.027 DBMET03167 0.119 0.02 DBMET03164 0.11 0.023 DBMET03166 0.081 0.041 DBMET03168 | DBMET03165 | |
| 0.023 | 0.079 | 0.046 | Membrane dipeptidase inhibitor | 0.046 0.019 DBMET03165 0.04 0.027 DBMET03164 0.041 0.024 DBMET03166 0.035 0.034 DBMET03168 | DBMET03165 | |
| 0.122 | 0.178 | 0.271 | Phospholipase C inhibitor | 0.174 0.068 DBMET03152 0.137 0.135 DBMET03161 0.15 0.106 DBMET03162 0.271 0.021 DBMET03165 0.198 0.045 DBMET03167 0.185 0.056 DBMET03164 0.182 0.059 DBMET03166 0.157 0.093 DBMET03168 | DBMET03165 | |
| 0.112 | 0.169 | 0.311 | Hepatoprotectant | 0.311 0.027 DBMET03169 0.141 0.119 DBMET03164 | DBMET03169 | |
| 0.051 | 0.11 | 0.134 | GABA aminotransferase inhibitor | 0.134 0.011 DBMET03165 0.103 0.025 DBMET03167 0.071 0.059 DBMET03166 | DBMET03165 | |
| 0.028 | 0.089 | 0.086 | Beta 2 adrenoreceptor antagonist | 0.058 0.026 DBMET03161 0.049 0.038 DBMET03162 0.086 0.01 DBMET03165 0.065 0.02 DBMET03167 0.068 0.018 DBMET03164 0.085 0.01 DBMET03166 0.069 0.017 DBMET03168 | DBMET03165 | |
| 0.023 | 0.084 | 0.07 | Ribonucleoside-diphosphate reductase inhibitor | 0.046 0.044 DBMET03162 0.054 0.038 DBMET03165 0.046 0.044 DBMET03167 0.07 0.029 DBMET03164 0.054 0.038 DBMET03166 0.062 0.033 DBMET03168 | DBMET03164 | |
| 0.046 | 0.108 | 0.095 | Topoisomerase II alpha inhibitor | 0.095 0.042 DBMET03169 | DBMET03169 | |
| 0.011 | 0.074 | 0.022 | Tryptophan hydroxylase 1 inhibitor | 0.022 0.005 DBMET03165 0.019 0.008 DBMET03167 0.018 0.011 DBMET03166 | DBMET03165 | |
| 0.01 | 0.073 | 0.028 | Kainate receptor 4 antagonist | 0.028 0.015 DBMET03167 | DBMET03167 | |
| 0.044 | 0.107 | 0.064 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.045 DBMET03168 | DBMET03168 | |
| 0.071 | 0.135 | 0.136 | M18 aspartyl aminopeptidase inhibitor | 0.132 0.062 DBMET03161 0.101 0.09 DBMET03162 0.136 0.059 DBMET03167 0.105 0.085 DBMET03168 | DBMET03167 | |
| 0.031 | 0.095 | 0.052 | Glucose-6-phosphate isomerase inhibitor | 0.043 0.042 DBMET03162 0.052 0.027 DBMET03165 0.045 0.039 DBMET03167 | DBMET03165 | |
| 0.016 | 0.081 | 0.024 | Integrin alpha2beta1 antagonist | 0.024 0.022 DBMET03162 | DBMET03162 | |
| 0.021 | 0.087 | 0.071 | Ribonucleotide reductase inhibitor | 0.057 0.038 DBMET03165 0.046 0.045 DBMET03167 0.071 0.031 DBMET03164 0.054 0.039 DBMET03166 0.063 0.035 DBMET03168 | DBMET03164 | |
| 0.032 | 0.102 | 0.047 | Cathepsin D inhibitor | 0.047 0.045 DBMET03168 | DBMET03168 | |
| 0.068 | 0.138 | 0.112 | DNA polymerase I inhibitor | 0.112 0.075 DBMET03169 | DBMET03169 | |
| 0.031 | 0.101 | 0.132 | NMDA receptor glycine site agonist | 0.055 0.052 DB00446 0.058 0.048 DBMET03158 0.086 0.025 DBMET03161 0.107 0.013 DBMET03162 0.106 0.014 DBMET03165 0.114 0.011 DBMET03167 0.07 0.036 DBMET03159 0.108 0.013 DBMET03164 0.132 0.006 DBMET03166 0.118 0.009 DBMET03168 | DBMET03166 | |
| 0.031 | 0.102 | 0.331 | Selectin antagonist | 0.166 0.015 DBMET03152 0.331 0.004 DBMET03169 0.072 0.041 DBMET03164 0.079 0.037 DBMET03166 | DBMET03169 | |
| 0.061 | 0.132 | 0.206 | Expectorant | 0.093 0.077 DBMET03162 0.192 0.022 DBMET03165 0.101 0.067 DBMET03167 0.09 0.081 DBMET03169 0.135 0.042 DBMET03164 0.206 0.019 DBMET03166 0.123 0.049 DBMET03168 | DBMET03166 | |
| 0.014 | 0.085 | 0.044 | Methionyl aminopeptidase 1 inhibitor | 0.03 0.026 DBMET03161 0.033 0.021 DBMET03165 0.044 0.009 DBMET03167 0.044 0.009 DBMET03166 0.036 0.016 DBMET03168 | DBMET03166 | |
| 0.011 | 0.083 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.024 0.013 DBMET03165 0.026 0.009 DBMET03167 | DBMET03167 | |
| 0.028 | 0.101 | 0.067 | Kainate receptor agonist | 0.045 0.022 DBMET03162 0.047 0.018 DBMET03165 0.067 0.005 DBMET03167 | DBMET03167 | |
| 0.122 | 0.196 | 0.441 | Spasmolytic | 0.186 0.132 DBMET03161 0.195 0.124 DBMET03162 0.441 0.033 DBMET03165 0.359 0.05 DBMET03167 0.237 0.097 DBMET03163 0.192 0.126 DBMET03164 0.341 0.055 DBMET03166 0.285 0.076 DBMET03168 | DBMET03165 | |
| 0.02 | 0.095 | 0.058 | Erythropoietin receptor agonist | 0.058 0.018 DBMET03164 | DBMET03164 | |
| 0.027 | 0.102 | 0.043 | Glucagon-like peptide 1 receptor antagonist | 0.043 0.021 DBMET03161 | DBMET03161 | |
| 0.103 | 0.179 | 0.174 | Melanin inhibitor | 0.141 0.095 DBMET03161 0.143 0.092 DBMET03162 0.153 0.077 DBMET03165 0.174 0.056 DBMET03167 0.126 0.122 DBMET03164 0.143 0.092 DBMET03166 0.144 0.09 DBMET03168 | DBMET03167 | |
| 0.104 | 0.182 | 0.186 | Interferon gamma antagonist | 0.141 0.09 DBMET03165 0.135 0.101 DBMET03167 0.186 0.047 DBMET03169 0.129 0.114 DBMET03168 | DBMET03169 | |
| 0.02 | 0.1 | 0.047 | Growth hormone release inhibitor | 0.047 0.024 DBMET03165 0.04 0.032 DBMET03166 | DBMET03165 | |
| 0.029 | 0.11 | 0.067 | Glutamate (mGluR group III) antagonist | 0.067 0.01 DBMET03167 | DBMET03167 | |
| 0.053 | 0.135 | 0.101 | Cell adhesion molecule inhibitor | 0.101 0.034 DBMET03169 | DBMET03169 | |
| 0.007 | 0.089 | 0.019 | Kainate receptor 5 antagonist | 0.019 0.016 DBMET03167 | DBMET03167 | |
| 0.015 | 0.098 | 0.04 | Calcitonin receptor agonist | 0.04 0.02 DBMET03165 0.035 0.023 DBMET03164 0.033 0.024 DBMET03166 0.029 0.028 DBMET03168 | DBMET03165 | |
| 0.077 | 0.163 | 0.168 | Cell adhesion inhibitor | 0.168 0.036 DBMET03169 | DBMET03169 | |
| 0.029 | 0.114 | 0.084 | Glucagon-like peptide 1 agonist | 0.057 0.05 DBMET03162 0.077 0.037 DBMET03165 0.064 0.046 DBMET03167 0.084 0.032 DBMET03164 0.071 0.041 DBMET03166 | DBMET03164 | |
| 0.052 | 0.138 | 0.187 | Urease inhibitor | 0.111 0.055 DB00446 0.147 0.025 DBMET03161 0.133 0.033 DBMET03162 0.116 0.049 DBMET03165 0.187 0.012 DBMET03167 0.093 0.075 DBMET03163 0.126 0.039 DBMET03164 0.13 0.036 DBMET03166 0.152 0.022 DBMET03168 | DBMET03167 | |
| 0.023 | 0.109 | 0.037 | Glutamate (mGluR8) antagonist | 0.037 0.021 DBMET03165 | DBMET03165 | |
| 0.058 | 0.145 | 0.273 | UDP-glucose 4-epimerase inhibitor | 0.134 0.035 DB00446 0.13 0.037 DBMET03158 0.202 0.018 DBMET03161 0.169 0.023 DBMET03162 0.123 0.041 DBMET03165 0.24 0.014 DBMET03167 0.273 0.012 DBMET03169 0.155 0.027 DBMET03159 0.125 0.04 DBMET03163 0.132 0.036 DBMET03164 0.13 0.037 DBMET03166 0.246 0.014 DBMET03168 0.111 0.05 DBMET03160 | DBMET03169 | |
| 0.065 | 0.155 | 0.264 | Amylase inhibitor | 0.15 0.064 DBMET03161 0.179 0.052 DBMET03162 0.249 0.028 DBMET03165 0.264 0.024 DBMET03167 0.262 0.025 DBMET03169 0.161 0.059 DBMET03164 0.099 0.097 DBMET03166 0.143 0.067 DBMET03168 | DBMET03167 | |
| 0.015 | 0.108 | 0.053 | Somatostatin 1 antagonist | 0.053 0.018 DBMET03165 0.044 0.023 DBMET03167 0.035 0.03 DBMET03166 | DBMET03165 | |
| 0.012 | 0.105 | 0.049 | Carbonic anhydrase IV inhibitor | 0.049 0.025 DBMET03164 | DBMET03164 | |
| 0.024 | 0.118 | 0.055 | Plasminogen activator inhibitor antagonist | 0.055 0.027 DBMET03162 0.044 0.04 DBMET03164 | DBMET03162 | |
| 0.015 | 0.109 | 0.124 | NMDA receptor subunit 3A antagonist | 0.075 0.013 DBMET03162 0.08 0.012 DBMET03165 0.124 0.006 DBMET03167 0.064 0.016 DBMET03164 | DBMET03167 | |
| 0.044 | 0.14 | 0.121 | Somatostatin 1 agonist | 0.071 0.063 DBMET03161 0.121 0.023 DBMET03165 0.1 0.034 DBMET03167 0.103 0.032 DBMET03166 0.072 0.062 DBMET03168 | DBMET03165 | |
| 0.209 | 0.307 | 0.462 | Caspase 9 stimulant | 0.27 0.229 DB00446 0.406 0.108 DBMET03161 0.412 0.104 DBMET03162 0.279 0.217 DBMET03165 0.438 0.089 DBMET03167 0.258 0.243 DBMET03169 0.318 0.175 DBMET03159 0.335 0.158 DBMET03164 0.345 0.149 DBMET03166 0.462 0.077 DBMET03168 | DBMET03168 | |
| 0.054 | 0.151 | 0.171 | Aminoacyl-tRNA synthetase inhibitor | 0.08 0.078 DBMET03161 0.171 0.014 DBMET03165 0.135 0.024 DBMET03167 0.085 0.068 DBMET03164 0.131 0.025 DBMET03166 | DBMET03165 | |
| 0.057 | 0.156 | 0.276 | Ferrochelatase inhibitor | 0.093 0.078 DBMET03161 0.132 0.046 DBMET03162 0.208 0.021 DBMET03165 0.151 0.037 DBMET03167 0.276 0.01 DBMET03166 0.104 0.067 DBMET03168 | DBMET03166 | |
| 0.015 | 0.115 | 0.043 | Growth factor receptor-bound protein 2 antagonist | 0.043 0.01 DBMET03162 | DBMET03162 | |
| 0.028 | 0.128 | 0.049 | Leukotriene B4 antagonist | 0.049 0.046 DBMET03165 | DBMET03165 | |
| 0.065 | 0.166 | 0.082 | T cell inhibitor | 0.082 0.058 DBMET03164 | DBMET03164 | |
| 0.013 | 0.119 | 0.038 | Cathepsin L2 inhibitor | 0.038 0.03 DBMET03168 | DBMET03168 | |
| 0.114 | 0.222 | 0.179 | Neurotensin receptor agonist | 0.161 0.078 DBMET03161 0.168 0.064 DBMET03162 0.142 0.122 DBMET03165 0.17 0.063 DBMET03167 0.16 0.08 DBMET03164 0.146 0.11 DBMET03166 0.179 0.051 DBMET03168 | DBMET03168 | |
| 0.045 | 0.155 | 0.11 | Glutamate (mGluR6) antagonist | 0.11 0.007 DBMET03165 0.083 0.021 DBMET03167 0.081 0.023 DBMET03166 | DBMET03165 | |
| 0.021 | 0.133 | 0.095 | Neuraminidase (Influenza A) inhibitor | 0.058 0.014 DBMET03165 0.095 0.004 DBMET03166 0.066 0.009 DBMET03168 | DBMET03166 | |
| 0.009 | 0.121 | 0.036 | Lysine carboxypeptidase inhibitor | 0.036 0.012 DBMET03165 | DBMET03165 | |
| 0.039 | 0.153 | 0.077 | Metalloproteinase-2 inhibitor | 0.077 0.056 DBMET03164 | DBMET03164 | |
| 0.056 | 0.169 | 0.132 | Anabolic | 0.092 0.075 DBMET03161 0.094 0.071 DBMET03162 0.132 0.029 DBMET03165 0.117 0.042 DBMET03167 0.103 0.058 DBMET03164 0.116 0.043 DBMET03166 0.102 0.06 DBMET03168 | DBMET03165 | |
| 0.009 | 0.123 | 0.027 | AMPA 2 receptor antagonist | 0.027 0.023 DBMET03167 | DBMET03167 | |
| 0.019 | 0.135 | 0.132 | NMDA receptor subunit 3B antagonist | 0.046 0.028 DBMET03162 0.055 0.021 DBMET03165 0.132 0.008 DBMET03167 0.06 0.019 DBMET03164 | DBMET03167 | |
| 0.029 | 0.147 | 0.045 | Bombesin 2 receptor antagonist | 0.045 0.042 DBMET03164 | DBMET03164 | |
| 0.04 | 0.159 | 0.12 | Ornithine decarboxylase inhibitor | 0.12 0.026 DBMET03165 0.106 0.038 DBMET03167 0.096 0.048 DBMET03166 | DBMET03165 | |
| 0.019 | 0.14 | 0.089 | Neutrophil collagenase inhibitor | 0.089 0.027 DBMET03164 0.058 0.053 DBMET03168 | DBMET03164 | |
| 0.025 | 0.147 | 0.056 | Aconitate hydratase inhibitor | 0.056 0.03 DBMET03165 | DBMET03165 | |
| 0.007 | 0.128 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.011 DBMET03165 0.014 0.013 DBMET03167 | DBMET03165 | |
| 0.048 | 0.171 | 0.231 | HIV-1 integrase (Overall Integration) inhibitor | 0.103 0.052 DBMET03161 0.137 0.03 DBMET03162 0.231 0.007 DBMET03165 0.204 0.011 DBMET03167 0.158 0.023 DBMET03164 0.111 0.045 DBMET03166 0.123 0.037 DBMET03168 | DBMET03165 | |
| 0.059 | 0.183 | 0.107 | Vanilloid agonist | 0.107 0.027 DBMET03163 | DBMET03163 | |
| 0.12 | 0.246 | 0.497 | Superoxide dismutase inhibitor | 0.2 0.118 DB00446 0.47 0.016 DBMET03152 0.285 0.056 DBMET03161 0.322 0.043 DBMET03162 0.303 0.049 DBMET03165 0.497 0.013 DBMET03167 0.166 0.162 DBMET03159 0.174 0.15 DBMET03163 0.339 0.039 DBMET03164 0.22 0.098 DBMET03166 0.392 0.028 DBMET03168 | DBMET03167 | |
| 0.003 | 0.129 | 0.014 | Beta 3 adrenoreceptor agonist | 0.014 0.006 DBMET03165 0.014 0.006 DBMET03166 | DBMET03166 | |
| 0.101 | 0.228 | 0.251 | Lipocortins synthesis antagonist | 0.251 0.033 DBMET03165 | DBMET03165 | |
| 0.093 | 0.22 | 0.231 | Interleukin 6 antagonist | 0.141 0.104 DBMET03162 0.231 0.028 DBMET03165 0.204 0.039 DBMET03167 0.146 0.095 DBMET03164 0.154 0.084 DBMET03168 | DBMET03165 | |
| 0.021 | 0.149 | 0.222 | Alcohol oxidase inhibitor | 0.078 0.025 DBMET03161 0.115 0.015 DBMET03162 0.112 0.015 DBMET03165 0.222 0.005 DBMET03167 0.067 0.031 DBMET03164 0.109 0.016 DBMET03166 0.131 0.012 DBMET03168 | DBMET03167 | |
| 0.01 | 0.138 | 0.065 | Kainate receptor antagonist | 0.036 0.033 DBMET03162 0.04 0.029 DBMET03165 0.065 0.014 DBMET03167 0.039 0.03 DBMET03164 | DBMET03167 | |
| 0.074 | 0.203 | 0.174 | Protein kinase stimulant | 0.174 0.053 DBMET03165 0.141 0.074 DBMET03167 0.151 0.067 DBMET03166 | DBMET03165 | |
| 0.003 | 0.133 | 0.029 | Kainate receptor 1 antagonist | 0.029 0.011 DBMET03167 | DBMET03167 | |
| 0.009 | 0.139 | 0.028 | Bradykinin B2 receptor agonist | 0.026 0.023 DBMET03165 0.028 0.02 DBMET03166 | DBMET03166 | |
| 0.054 | 0.186 | 0.102 | Glutamate receptor antagonist | 0.102 0.094 DBMET03167 | DBMET03167 | |
| 0.021 | 0.155 | 0.097 | Glutamate (mGluR group III) agonist | 0.046 0.026 DBMET03165 0.097 0.01 DBMET03167 | DBMET03167 | |
| 0.029 | 0.165 | 0.084 | Porphobilinogen synthase inhibitor | 0.084 0.045 DBMET03167 | DBMET03167 | |
| 0.049 | 0.186 | 0.182 | GABA C receptor agonist | 0.182 0.024 DBMET03165 0.113 0.055 DBMET03167 | DBMET03165 | |
| 0.009 | 0.147 | 0.023 | Somatostatin 4 antagonist | 0.023 0.017 DBMET03165 | DBMET03165 | |
| 0.063 | 0.202 | 0.203 | DOPA decarboxylase inhibitor | 0.096 0.085 DB00446 0.124 0.04 DBMET03161 0.14 0.027 DBMET03162 0.154 0.019 DBMET03165 0.203 0.006 DBMET03167 0.106 0.064 DBMET03164 0.104 0.068 DBMET03166 0.118 0.047 DBMET03168 | DBMET03167 | |
| 0.008 | 0.151 | 0.06 | Kainate receptor 2 antagonist | 0.06 0.012 DBMET03167 | DBMET03167 | |
| 0.008 | 0.155 | 0.028 | AMPA 3 receptor antagonist | 0.028 0.021 DBMET03167 | DBMET03167 | |
| 0.035 | 0.184 | 0.132 | Monophenol monooxygenase inhibitor | 0.127 0.057 DBMET03165 0.132 0.055 DBMET03167 0.1 0.076 DBMET03169 0.11 0.069 DBMET03166 0.093 0.081 DBMET03168 | DBMET03167 | |
| 0.035 | 0.185 | 0.077 | Metalloproteinase-9 inhibitor | 0.077 0.047 DBMET03164 | DBMET03164 | |
| 0.032 | 0.184 | 0.144 | Calcium antagonist | 0.099 0.049 DBMET03161 0.086 0.059 DBMET03162 0.144 0.024 DBMET03167 0.072 0.071 DBMET03164 0.108 0.042 DBMET03168 | DBMET03167 | |
| 0.035 | 0.188 | 0.058 | Adenine nucleotide translocase inhibitor | 0.058 0.032 DBMET03169 | DBMET03169 | |
| 0.007 | 0.16 | 0.037 | Beta 1 adrenoreceptor agonist | 0.037 0.005 DBMET03165 0.024 0.014 DBMET03167 0.037 0.005 DBMET03166 0.021 0.019 DBMET03168 | DBMET03166 | |
| 0.004 | 0.158 | 0.051 | AMPA 1 receptor antagonist | 0.051 0.011 DBMET03162 0.034 0.018 DBMET03164 | DBMET03162 | |
| 0.016 | 0.171 | 0.035 | Glutamate (mGluR3) agonist | 0.035 0.016 DBMET03165 0.03 0.029 DBMET03167 0.031 0.026 DBMET03166 | DBMET03165 | |
| 0.037 | 0.192 | 0.139 | Interferon agonist | 0.083 0.048 DBMET03161 0.074 0.063 DBMET03162 0.139 0.012 DBMET03165 0.103 0.027 DBMET03167 0.071 0.068 DBMET03169 0.087 0.043 DBMET03166 0.092 0.036 DBMET03168 | DBMET03165 | |
| 0.035 | 0.191 | 0.102 | Interferon inducer | 0.071 0.033 DBMET03161 0.062 0.049 DBMET03162 0.102 0.012 DBMET03165 0.086 0.019 DBMET03167 0.062 0.05 DBMET03169 0.071 0.033 DBMET03166 0.079 0.024 DBMET03168 | DBMET03165 | |
| 0.017 | 0.173 | 0.052 | AMPA 4 receptor antagonist | 0.039 0.029 DBMET03162 0.043 0.022 DBMET03165 0.052 0.014 DBMET03167 0.037 0.033 DBMET03164 | DBMET03167 | |
| 0.026 | 0.182 | 0.072 | Beta adrenoreceptor agonist | 0.048 0.023 DBMET03161 0.046 0.029 DBMET03162 0.072 0.005 DBMET03165 0.052 0.015 DBMET03167 0.048 0.022 DBMET03164 0.069 0.005 DBMET03166 0.049 0.021 DBMET03168 | DBMET03165 | |
| 0.008 | 0.176 | 0.04 | Neuraminidase (Influenza B) inhibitor | 0.025 0.008 DBMET03165 0.04 0.003 DBMET03166 0.025 0.008 DBMET03168 | DBMET03166 | |
| 0.019 | 0.186 | 0.102 | Antineoplastic antibiotic | 0.102 0.045 DBMET03169 | DBMET03169 | |
| 0.071 | 0.241 | 0.15 | Arachidonic acid antagonist | 0.15 0.088 DBMET03165 | DBMET03165 | |
| 0.034 | 0.204 | 0.128 | Beta 3 adrenoreceptor antagonist | 0.067 0.038 DBMET03161 0.115 0.011 DBMET03165 0.072 0.032 DBMET03167 0.128 0.008 DBMET03166 0.092 0.017 DBMET03168 | DBMET03166 | |
| 0.044 | 0.22 | 0.071 | Vanilloid 4 agonist | 0.069 0.068 DBMET03161 0.071 0.06 DBMET03168 | DBMET03168 | |
| 0.109 | 0.288 | 0.232 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.15 0.149 DBMET03161 0.155 0.138 DBMET03162 0.232 0.051 DBMET03165 0.197 0.074 DBMET03167 0.184 0.088 DBMET03166 0.16 0.126 DBMET03168 | DBMET03165 | |
| 0.057 | 0.239 | 0.103 | Electron transport complex I inhibitor | 0.097 0.089 DBMET03161 0.096 0.093 DBMET03167 0.103 0.076 DBMET03168 | DBMET03168 | |
| 0.007 | 0.19 | 0.017 | Factor IX inhibitor | 0.017 0.014 DBMET03165 | DBMET03165 | |
| 0.025 | 0.209 | 0.061 | Botulinum neurotoxin type A inhibitor | 0.061 0.035 DBMET03167 0.06 0.037 DBMET03164 0.058 0.04 DBMET03168 | DBMET03167 | |
| 0.011 | 0.196 | 0.029 | Glutamate (mGluR1) agonist | 0.029 0.01 DBMET03152 0.024 0.018 DBMET03167 | DBMET03152 | |
| 0.009 | 0.195 | 0.036 | Dihydropteroate synthase inhibitor | 0.036 0.033 DBMET03165 | DBMET03165 | |
| 0.082 | 0.271 | 0.336 | Free radical scavenger | 0.336 0.042 DBMET03169 | DBMET03169 | |
| 0.037 | 0.226 | 0.087 | Beta 2 adrenoreceptor agonist | 0.065 0.03 DBMET03161 0.06 0.049 DBMET03162 0.087 0.006 DBMET03165 0.071 0.018 DBMET03167 0.066 0.028 DBMET03164 0.084 0.007 DBMET03166 0.066 0.027 DBMET03168 | DBMET03165 | |
| 0.028 | 0.217 | 0.078 | Purinergic P2X1 antagonist | 0.078 0.026 DBMET03165 0.066 0.035 DBMET03167 | DBMET03165 | |
| 0.017 | 0.208 | 0.042 | Phenylethanolamine N methyltransferase inhibitor | 0.042 0.025 DBMET03167 | DBMET03167 | |
| 0.026 | 0.218 | 0.073 | Sirtuin 1 inhibitor | 0.066 0.05 DBMET03166 0.073 0.041 DBMET03168 | DBMET03168 | |
| 0.007 | 0.199 | 0.041 | Phosphoglycerate kinase inhibitor | 0.041 0.018 DBMET03165 0.031 0.029 DBMET03167 | DBMET03165 | |
| 0.108 | 0.3 | 0.213 | Gastrin inhibitor | 0.211 0.133 DBMET03162 0.213 0.13 DBMET03164 0.201 0.148 DBMET03166 | DBMET03164 | |
| 0.06 | 0.252 | 0.656 | Peroxidase inhibitor | 0.112 0.109 DB00446 0.234 0.051 DBMET03161 0.273 0.043 DBMET03162 0.656 0.004 DBMET03165 0.476 0.012 DBMET03167 0.413 0.019 DBMET03164 0.522 0.008 DBMET03166 0.223 0.053 DBMET03168 | DBMET03165 | |
| 0.019 | 0.212 | 0.066 | HIV-1 integrase (3'-Processing) inhibitor | 0.066 0.042 DBMET03163 | DBMET03163 | |
| 0.047 | 0.245 | 0.137 | Lanosterol 14 alpha demethylase inhibitor | 0.137 0.017 DBMET03165 0.125 0.026 DBMET03167 0.093 0.067 DBMET03166 | DBMET03165 | |
| 0.095 | 0.294 | 0.24 | DNA damaging | 0.179 0.135 DBMET03165 0.24 0.086 DBMET03167 | DBMET03167 | |
| 0.072 | 0.273 | 0.256 | Platelet adhesion inhibitor | 0.198 0.072 DBMET03161 0.177 0.084 DBMET03162 0.139 0.12 DBMET03167 0.256 0.047 DBMET03169 0.149 0.106 DBMET03159 0.154 0.102 DBMET03164 | DBMET03169 | |
| 0.015 | 0.217 | 0.034 | Glutamate (mGluR4) agonist | 0.034 0.022 DBMET03167 | DBMET03167 | |
| 0.085 | 0.288 | 0.352 | Antioxidant | 0.352 0.046 DBMET03169 | DBMET03169 | |
| 0.135 | 0.339 | 0.383 | Calcium channel activator | 0.212 0.196 DB00446 0.211 0.197 DBMET03158 0.304 0.088 DBMET03161 0.305 0.086 DBMET03162 0.29 0.102 DBMET03165 0.383 0.031 DBMET03167 0.239 0.161 DBMET03164 0.308 0.084 DBMET03168 | DBMET03167 | |
| 0.006 | 0.213 | 0.06 | Sodium/glucose cotransporter 2 inhibitor | 0.06 0.005 DBMET03169 | DBMET03169 | |
| 0.023 | 0.23 | 0.119 | Factor IXa inhibitor | 0.097 0.01 DBMET03152 0.088 0.013 DBMET03161 0.046 0.043 DBMET03162 0.119 0.006 DBMET03165 0.079 0.016 DBMET03167 0.066 0.022 DBMET03169 0.118 0.006 DBMET03166 0.051 0.037 DBMET03168 | DBMET03165 | |
| 0.028 | 0.237 | 0.231 | Protein-tyrosine phosphatase 1B inhibitor | 0.231 0.021 DBMET03162 | DBMET03162 | |
| 0.005 | 0.214 | 0.026 | Uridine phosphorylase inhibitor | 0.026 0.021 DBMET03167 | DBMET03167 | |
| 0.105 | 0.314 | 0.154 | Ca2+-transporting ATPase inhibitor | 0.154 0.034 DBMET03165 0.142 0.067 DBMET03167 0.132 0.107 DBMET03166 | DBMET03165 | |
| 0.032 | 0.245 | 0.057 | Kallikrein 1 inhibitor | 0.057 0.038 DBMET03165 0.056 0.04 DBMET03166 | DBMET03165 | |
| 0.026 | 0.239 | 0.044 | Heme oxygenase inhibitor | 0.042 0.032 DBMET03165 0.044 0.025 DBMET03167 | DBMET03167 | |
| 0.003 | 0.216 | 0.047 | Arginase inhibitor | 0.047 0.017 DBMET03165 | DBMET03165 | |
| 0.014 | 0.227 | 0.053 | HIV-1 integrase (Strand Transfer) inhibitor | 0.053 0.047 DBMET03163 | DBMET03163 | |
| 0.026 | 0.243 | 0.129 | CDC25A inhibitor | 0.129 0.017 DBMET03152 | DBMET03152 | |
| 0.018 | 0.236 | 0.28 | Protein kinase C eta inhibitor | 0.28 0.003 DBMET03165 0.256 0.003 DBMET03167 0.235 0.003 DBMET03166 | DBMET03165 | |
| 0.059 | 0.278 | 0.133 | Diuretic | 0.133 0.091 DBMET03165 0.114 0.112 DBMET03166 | DBMET03165 | |
| 0.051 | 0.274 | 0.186 | Antibacterial (Helicobacter pylori) | 0.159 0.039 DBMET03161 0.112 0.094 DBMET03162 0.108 0.102 DBMET03165 0.168 0.034 DBMET03167 0.141 0.054 DBMET03166 0.186 0.026 DBMET03168 | DBMET03168 | |
| 0.017 | 0.239 | 0.055 | Antibiotic Aminoglycoside-like | 0.033 0.03 DBMET03165 0.055 0.011 DBMET03169 0.034 0.029 DBMET03163 | DBMET03169 | |
| 0.051 | 0.275 | 0.241 | Toll-Like receptor 3 antagonist | 0.241 0.004 DBMET03165 0.104 0.045 DBMET03167 0.115 0.034 DBMET03166 | DBMET03165 | |
| 0.038 | 0.263 | 0.132 | Chelator | 0.132 0.044 DBMET03164 | DBMET03164 | |
| 0.014 | 0.242 | 0.033 | Purinergic P2Y2 antagonist | 0.033 0.024 DBMET03152 | DBMET03152 | |
| 0.005 | 0.237 | 0.153 | Sphingosine 1-phosphate receptor 3 agonist | 0.153 0.004 DBMET03161 | DBMET03161 | |
| 0.012 | 0.245 | 0.026 | Thrombin receptor antagonist | 0.026 0.023 DBMET03165 | DBMET03165 | |
| 0.07 | 0.305 | 0.135 | DNA repair enzyme inhibitor | 0.133 0.05 DBMET03165 0.135 0.047 DBMET03167 0.121 0.07 DBMET03169 0.107 0.106 DBMET03166 | DBMET03167 | |
| 0.053 | 0.289 | 0.109 | Glutamate release inhibitor | 0.109 0.031 DBMET03165 | DBMET03165 | |
| 0.013 | 0.25 | 0.063 | Acyl-CoA dehydrogenase inhibitor | 0.063 0.031 DBMET03165 | DBMET03165 | |
| 0.006 | 0.249 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.01 DBMET03165 | DBMET03165 | |
| 0.043 | 0.291 | 0.288 | Adenylate cyclase inhibitor | 0.095 0.089 DBMET03162 0.288 0.015 DBMET03165 0.14 0.052 DBMET03167 0.119 0.068 DBMET03164 0.187 0.028 DBMET03166 0.099 0.086 DBMET03168 | DBMET03165 | |
| 0.007 | 0.257 | 0.026 | LFA antagonist | 0.026 0.022 DBMET03164 | DBMET03164 | |
| 0.008 | 0.258 | 0.242 | NMDA 2 receptor antagonist | 0.159 0.015 DBMET03161 0.075 0.047 DBMET03162 0.201 0.009 DBMET03165 0.242 0.006 DBMET03167 0.123 0.023 DBMET03164 0.112 0.027 DBMET03166 0.086 0.04 DBMET03168 | DBMET03167 | |
| 0.042 | 0.292 | 0.291 | Protein-tyrosine phosphatase inhibitor | 0.128 0.104 DBMET03152 0.291 0.021 DBMET03162 | DBMET03162 | |
| 0.049 | 0.3 | 0.144 | Glutamate (mGluR7) agonist | 0.111 0.041 DBMET03165 0.089 0.085 DBMET03167 0.144 0.014 DBMET03166 | DBMET03166 | |
| 0.022 | 0.273 | 0.049 | CXC chemokine 1 receptor antagonist | 0.049 0.038 DBMET03163 | DBMET03163 | |
| 0.018 | 0.27 | 0.071 | Na+ K+ transporting ATPase inhibitor | 0.071 0.059 DBMET03165 0.068 0.062 DBMET03167 | DBMET03165 | |
| 0.024 | 0.277 | 0.089 | Adrenaline antagonist | 0.089 0.061 DBMET03165 | DBMET03165 | |
| 0.061 | 0.314 | 0.245 | Nitric oxide antagonist | 0.245 0.053 DBMET03169 | DBMET03169 | |
| 0.004 | 0.26 | 0.037 | Somatostatin 5 antagonist | 0.037 0.02 DBMET03165 | DBMET03165 | |
| 0.024 | 0.281 | 0.092 | Antiadrenergic | 0.092 0.061 DBMET03165 | DBMET03165 | |
| 0.049 | 0.305 | 0.261 | Anticoagulant | 0.261 0.036 DBMET03152 0.144 0.086 DBMET03164 | DBMET03152 | |
| 0.084 | 0.344 | 0.403 | Transcription factor NF kappa B inhibitor | 0.222 0.149 DBMET03161 0.208 0.161 DBMET03162 0.351 0.077 DBMET03165 0.286 0.102 DBMET03167 0.403 0.063 DBMET03169 0.268 0.114 DBMET03163 0.211 0.159 DBMET03164 0.272 0.112 DBMET03166 0.279 0.107 DBMET03168 | DBMET03169 | |
| 0.013 | 0.275 | 0.048 | Tryptophan 5 hydroxylase inhibitor | 0.048 0.006 DBMET03165 0.037 0.022 DBMET03167 0.035 0.026 DBMET03166 | DBMET03165 | |
| 0.048 | 0.311 | 0.081 | Estrogen-related receptor beta agonist | 0.081 0.063 DBMET03165 | DBMET03165 | |
| 0.008 | 0.272 | 0.089 | Urokinase inhibitor | 0.089 0.019 DBMET03165 0.066 0.026 DBMET03167 0.064 0.026 DBMET03166 | DBMET03165 | |
| 0.03 | 0.294 | 0.164 | Creatine kinase inhibitor | 0.097 0.063 DBMET03161 0.1 0.059 DBMET03162 0.121 0.04 DBMET03165 0.164 0.019 DBMET03167 0.101 0.059 DBMET03168 | DBMET03167 | |
| 0.031 | 0.298 | 0.071 | Gonadotropin-releasing hormone receptor agonist | 0.071 0.024 DBMET03165 0.055 0.05 DBMET03164 0.06 0.04 DBMET03166 0.055 0.052 DBMET03168 | DBMET03165 | |
| 0.095 | 0.364 | 0.302 | Neuropeptide Y2 antagonist | 0.218 0.092 DBMET03161 0.198 0.124 DBMET03162 0.271 0.038 DBMET03165 0.247 0.059 DBMET03167 0.222 0.086 DBMET03164 0.302 0.018 DBMET03166 0.27 0.039 DBMET03168 | DBMET03166 | |
| 0.145 | 0.418 | 0.534 | 5 Hydroxytryptamine release inhibitor | 0.283 0.185 DBMET03161 0.359 0.108 DBMET03162 0.465 0.045 DBMET03165 0.38 0.091 DBMET03167 0.534 0.023 DBMET03166 0.295 0.171 DBMET03168 | DBMET03166 | |
| 0.017 | 0.29 | 0.067 | Sphingosine 1-phosphate receptor 3 antagonist | 0.059 0.04 DBMET03165 0.062 0.035 DBMET03167 0.067 0.028 DBMET03166 | DBMET03166 | |
| 0.006 | 0.281 | 0.044 | Sodium/glucose cotransporter inhibitor | 0.044 0.006 DBMET03169 | DBMET03169 | |
| 0.004 | 0.279 | 0.055 | Cholecystokinin agonist | 0.055 0.006 DBMET03152 | DBMET03152 | |
| 0.024 | 0.303 | 0.107 | Alcohol dehydrogenase inhibitor | 0.107 0.045 DBMET03167 | DBMET03167 | |
| 0.027 | 0.307 | 0.089 | Mediator release inhibitor | 0.089 0.083 DBMET03166 | DBMET03166 | |
| 0.043 | 0.336 | 0.088 | D-Ala-D-Ala ligase inhibitor | 0.086 0.053 DBMET03165 0.088 0.048 DBMET03167 | DBMET03167 | |
| 0.01 | 0.304 | 0.034 | Factor XIIIa inhibitor | 0.034 0.03 DBMET03164 | DBMET03164 | |
| 0.053 | 0.352 | 0.146 | Sphingosine 1-phosphate receptor 4 antagonist | 0.146 0.037 DBMET03167 0.123 0.067 DBMET03166 0.11 0.094 DBMET03168 | DBMET03167 | |
| 0.012 | 0.315 | 0.072 | Plasminogen activator inhibitor | 0.063 0.037 DBMET03165 0.057 0.042 DBMET03167 0.054 0.044 DBMET03164 0.072 0.03 DBMET03166 | DBMET03166 | |
| 0.026 | 0.336 | 0.11 | Topoisomerase II inhibitor | 0.11 0.076 DBMET03169 | DBMET03169 | |
| 0.021 | 0.332 | 0.209 | Adrenaline agonist | 0.092 0.044 DBMET03161 0.078 0.06 DBMET03162 0.209 0.006 DBMET03165 0.134 0.019 DBMET03167 0.086 0.05 DBMET03164 0.18 0.009 DBMET03166 0.098 0.038 DBMET03168 | DBMET03165 | |
| 0.021 | 0.342 | 0.053 | Dihydroorotate oxidase inhibitor | 0.053 0.043 DBMET03166 | DBMET03166 | |
| 0.035 | 0.357 | 0.139 | NADH dehydrogenase inhibitor | 0.139 0.021 DBMET03165 0.099 0.045 DBMET03167 0.095 0.049 DBMET03169 0.083 0.068 DBMET03166 | DBMET03165 | |
| 0.022 | 0.346 | 0.086 | Potassium channel (Ca-activated) activator | 0.086 0.069 DBMET03167 | DBMET03167 | |
| 0.027 | 0.352 | 0.138 | Glycine receptor agonist | 0.138 0.009 DBMET03165 0.077 0.042 DBMET03167 0.079 0.039 DBMET03166 | DBMET03165 | |
| 0.046 | 0.372 | 0.159 | Histone deacetylase SIRT1 inhibitor | 0.117 0.095 DBMET03164 0.154 0.058 DBMET03166 0.159 0.054 DBMET03168 | DBMET03168 | |
| 0.04 | 0.37 | 0.351 | Dual specificity phosphatase inhibitor | 0.351 0.021 DBMET03152 | DBMET03152 | |
| 0.004 | 0.336 | 0.04 | Cholecystokinin A agonist | 0.04 0.005 DBMET03152 | DBMET03152 | |
| 0.088 | 0.428 | 0.269 | Insulysin inhibitor | 0.228 0.119 DBMET03165 0.189 0.174 DBMET03164 0.269 0.08 DBMET03166 | DBMET03166 | |
| 0.009 | 0.355 | 0.031 | Estrogen-related receptor gamma antagonist | 0.031 0.014 DBMET03165 0.03 0.015 DBMET03167 | DBMET03165 | |
| 0.021 | 0.376 | 0.061 | Glucosylceramidase inhibitor | 0.056 0.037 DBMET03161 0.061 0.03 DBMET03165 0.056 0.036 DBMET03167 0.053 0.042 DBMET03166 | DBMET03165 | |
| 0.048 | 0.404 | 0.15 | Transcription factor STAT6 inhibitor | 0.115 0.07 DBMET03161 0.112 0.077 DBMET03165 0.13 0.044 DBMET03167 0.124 0.052 DBMET03166 0.15 0.023 DBMET03168 | DBMET03168 | |
| 0.038 | 0.397 | 0.112 | Interleukin 8 antagonist | 0.104 0.087 DBMET03165 0.112 0.073 DBMET03167 | DBMET03167 | |
| 0.058 | 0.423 | 0.18 | 12-Lipoxygenase inhibitor | 0.18 0.173 DBMET03168 | DBMET03168 | |
| 0.055 | 0.423 | 0.304 | Cardiotonic | 0.21 0.11 DBMET03161 0.285 0.063 DBMET03162 0.171 0.15 DBMET03165 0.177 0.143 DBMET03167 0.304 0.054 DBMET03164 0.261 0.075 DBMET03168 | DBMET03164 | |
| 0.004 | 0.374 | 0.022 | Protease (Human cytomegalovirus) inhibitor | 0.022 0.016 DBMET03168 | DBMET03168 | |
| 0.11 | 0.48 | 0.261 | 5 Hydroxytryptamine uptake stimulant | 0.261 0.071 DBMET03165 0.22 0.117 DBMET03167 0.215 0.126 DBMET03166 | DBMET03165 | |
| 0.039 | 0.412 | 0.149 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.149 0.144 DBMET03167 | DBMET03167 | |
| 0.005 | 0.38 | 0.047 | Protease activated receptor 1 antagonist | 0.047 0.034 DBMET03161 | DBMET03161 | |
| 0.006 | 0.388 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.019 DBMET03165 | DBMET03165 | |
| 0.004 | 0.388 | 0.043 | AMPA receptor antagonist | 0.043 0.039 DBMET03162 | DBMET03162 | |
| 0.098 | 0.482 | 0.473 | Cyclophilin D inhibitor | 0.235 0.23 DBMET03161 0.472 0.059 DBMET03162 0.324 0.143 DBMET03165 0.473 0.059 DBMET03169 0.314 0.15 DBMET03164 0.254 0.209 DBMET03166 0.252 0.211 DBMET03168 | DBMET03169 | |
| 0.075 | 0.462 | 0.308 | Toll-Like receptor agonist | 0.308 0.106 DBMET03162 0.236 0.161 DBMET03165 | DBMET03162 | |
| 0.046 | 0.435 | 0.267 | Insulin secretagoues | 0.267 0.017 DBMET03163 | DBMET03163 | |
| 0.027 | 0.416 | 0.058 | Immunoglobulin Fc receptor antagonist | 0.058 0.028 DBMET03165 | DBMET03165 | |
| 0.057 | 0.452 | 0.218 | Transcription factor STAT3 inhibitor | 0.218 0.113 DBMET03168 | DBMET03168 | |
| 0.01 | 0.407 | 0.057 | Adenosine deaminase inhibitor | 0.057 0.023 DBMET03165 | DBMET03165 | |
| 0.013 | 0.412 | 0.055 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.055 0.01 DBMET03165 0.04 0.034 DBMET03167 | DBMET03165 | |
| 0.004 | 0.405 | 0.121 | Diamine oxidase inhibitor | 0.085 0.005 DBMET03165 0.065 0.008 DBMET03167 0.121 0.004 DBMET03166 0.038 0.025 DBMET03168 | DBMET03166 | |
| 0.049 | 0.458 | 0.165 | Cyclic AMP phosphodiesterase inhibitor | 0.162 0.133 DBMET03165 0.165 0.129 DBMET03167 0.157 0.14 DBMET03168 | DBMET03167 | |
| 0.016 | 0.426 | 0.057 | Heparanase inhibitor | 0.057 0.027 DBMET03169 | DBMET03169 | |
| 0.023 | 0.434 | 0.076 | Keratolytic | 0.076 0.054 DBMET03165 0.071 0.064 DBMET03166 | DBMET03165 | |
| 0.031 | 0.445 | 0.181 | Mannose-6-phosphate isomerase inhibitor | 0.181 0.042 DBMET03167 | DBMET03167 | |
| 0.047 | 0.463 | 0.21 | 3C-like protease (Human coronavirus) inhibitor | 0.138 0.123 DBMET03161 0.21 0.046 DBMET03168 | DBMET03168 | |
| 0.028 | 0.45 | 0.324 | Dual specificity phosphatase 3 inhibitor | 0.324 0.025 DBMET03152 | DBMET03152 | |
| 0.039 | 0.463 | 0.156 | Sphingosine 1-phosphate receptor 2 antagonist | 0.12 0.095 DBMET03165 0.137 0.06 DBMET03167 0.156 0.033 DBMET03166 | DBMET03166 | |
| 0.019 | 0.444 | 0.247 | Protein kinase C gamma inhibitor | 0.247 0.007 DBMET03165 0.207 0.013 DBMET03167 0.187 0.017 DBMET03166 0.094 0.088 DBMET03168 | DBMET03165 | |
| 0.066 | 0.498 | 0.278 | Toll-Like receptor 7 agonist | 0.278 0.125 DBMET03162 | DBMET03162 | |
| 0.009 | 0.463 | 0.072 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.072 0.024 DBMET03165 | DBMET03165 | |
| 0.004 | 0.46 | 0.04 | Sphingosine 1-phosphate receptor 1 agonist | 0.04 0.033 DBMET03165 | DBMET03165 | |
| 0.028 | 0.484 | 0.086 | Granulocyte macrophage colony stimulating factor agonist | 0.086 0.059 DBMET03165 | DBMET03165 | |
| 0.085 | 0.542 | 0.134 | Heat shock protein 70 antagonist | 0.132 0.109 DBMET03165 0.134 0.1 DBMET03167 0.132 0.112 DBMET03166 0.13 0.119 DBMET03168 | DBMET03167 | |
| 0.003 | 0.461 | 0.028 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.026 DBMET03165 | DBMET03165 | |
| 0.017 | 0.477 | 0.133 | Cystathionine beta-synthase inhibitor | 0.133 0.049 DBMET03165 | DBMET03165 | |
| 0.006 | 0.473 | 0.022 | Toll-Like receptor 8 agonist | 0.022 0.01 DBMET03165 0.019 0.018 DBMET03166 | DBMET03165 | |
| 0.007 | 0.482 | 0.022 | Follicle-stimulating hormone antagonist | 0.022 0.009 DBMET03165 0.019 0.014 DBMET03167 0.019 0.014 DBMET03163 0.019 0.017 DBMET03166 | DBMET03165 | |
| 0.015 | 0.496 | 0.089 | Potassium channel activator | 0.086 0.066 DBMET03161 0.089 0.061 DBMET03168 | DBMET03168 | |
| 0.029 | 0.517 | 0.201 | Carbonic anhydrase XV inhibitor | 0.201 0.018 DBMET03165 0.124 0.043 DBMET03166 | DBMET03165 | |
| 0.044 | 0.535 | 0.227 | Neurotrophic factor enhancer | 0.227 0.054 DBMET03165 0.151 0.136 DBMET03166 | DBMET03165 | |
| 0.005 | 0.496 | 0.045 | Glutamate (mGluR3) antagonist | 0.045 0.016 DBMET03165 | DBMET03165 | |
| 0.019 | 0.517 | 0.16 | Pyruvate kinase inhibitor | 0.134 0.131 DBMET03165 0.16 0.107 DBMET03167 | DBMET03167 | |
| 0.044 | 0.544 | 0.23 | Transcription factor STAT inhibitor | 0.23 0.102 DBMET03168 | DBMET03168 | |
| 0.022 | 0.523 | 0.216 | Acetylcholine M1 receptor antagonist | 0.216 0.036 DBMET03165 0.165 0.062 DBMET03167 0.151 0.073 DBMET03166 | DBMET03165 | |
| 0.053 | 0.575 | 0.184 | RNA-directed DNA polymerase inhibitor | 0.184 0.125 DBMET03165 | DBMET03165 | |
| 0.027 | 0.56 | 0.349 | Aldehyde oxidase inhibitor | 0.349 0.055 DBMET03165 0.159 0.131 DBMET03167 | DBMET03165 | |
| 0.017 | 0.553 | 0.113 | Beta glucuronidase inhibitor | 0.113 0.053 DBMET03169 | DBMET03169 | |
| 0.039 | 0.585 | 0.162 | NOS3 expression enhancer | 0.162 0.062 DBMET03169 | DBMET03169 | |
| 0.013 | 0.568 | 0.113 | Acetylcholine muscarinic antagonist | 0.113 0.075 DBMET03165 | DBMET03165 | |
| 0.016 | 0.572 | 0.101 | Cholinergic antagonist | 0.101 0.094 DBMET03165 | DBMET03165 | |
| 0.007 | 0.571 | 0.242 | Protein kinase C alpha inhibitor | 0.242 0.004 DBMET03165 0.205 0.005 DBMET03167 0.177 0.007 DBMET03166 | DBMET03165 | |
| 0.015 | 0.581 | 0.099 | Acetylcholine antagonist | 0.099 0.094 DBMET03165 | DBMET03165 | |
| 0.007 | 0.579 | 0.12 | Inducible nitric-oxide synthase inhibitor | 0.12 0.025 DBMET03165 0.106 0.032 DBMET03167 | DBMET03165 | |
| 0.008 | 0.583 | 0.077 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.077 0.042 DBMET03165 0.076 0.045 DBMET03167 | DBMET03165 | |
| 0.004 | 0.58 | 0.038 | AMPA receptor agonist | 0.038 0.02 DBMET03162 | DBMET03162 | |
| 0.015 | 0.595 | 0.114 | GABA C receptor rho-1 antagonist | 0.114 0.046 DBMET03165 | DBMET03165 | |
| 0.008 | 0.588 | 0.064 | Epithelial sodium channel blocker | 0.064 0.023 DBMET03165 | DBMET03165 | |
| 0.009 | 0.61 | 0.153 | Nitric-oxide synthase inhibitor | 0.153 0.021 DBMET03165 0.122 0.036 DBMET03167 0.089 0.079 DBMET03166 | DBMET03165 | |
| 0.005 | 0.611 | 0.097 | Sphingosine kinase inhibitor | 0.089 0.011 DBMET03165 0.061 0.037 DBMET03167 0.097 0.008 DBMET03166 | DBMET03166 | |
| 0.005 | 0.618 | 0.071 | Sphingosine kinase 1 inhibitor | 0.059 0.01 DBMET03165 0.041 0.029 DBMET03167 0.071 0.006 DBMET03166 | DBMET03166 | |
| 0.005 | 0.623 | 0.058 | NMDA 2B receptor antagonist | 0.058 0.033 DBMET03152 0.048 0.047 DBMET03165 | DBMET03152 | |
| 0.004 | 0.624 | 0.05 | Protocollagen prolyl hydroxylase inhibitor | 0.05 0.005 DBMET03164 | DBMET03164 | |
| 0.011 | 0.633 | 0.128 | GABA C receptor antagonist | 0.128 0.045 DBMET03165 | DBMET03165 | |
| 0.052 | 0.674 | 0.325 | 5 Hydroxytryptamine release stimulant | 0.325 0.063 DBMET03165 0.189 0.131 DBMET03167 | DBMET03165 | |
| 0.053 | 0.677 | 0.143 | Papain-like protease (SARS coronavirus) inhibitor | 0.111 0.109 DBMET03165 0.143 0.042 DBMET03166 | DBMET03166 | |
| 0.023 | 0.648 | 0.129 | CDK3/cyclin E inhibitor | 0.129 0.045 DBMET03166 | DBMET03166 | |
| 0.019 | 0.645 | 0.175 | 5 Hydroxytryptamine 1E antagonist | 0.175 0.16 DBMET03167 | DBMET03167 | |
| 0.026 | 0.654 | 0.162 | Sphingosine 1-phosphate receptor 5 antagonist | 0.144 0.071 DBMET03167 0.162 0.044 DBMET03166 | DBMET03166 | |
| 0.005 | 0.662 | 0.237 | Protein kinase C epsilon inhibitor | 0.237 0.004 DBMET03165 0.193 0.004 DBMET03167 0.187 0.004 DBMET03166 | DBMET03165 | |
| 0.005 | 0.671 | 0.101 | Sphingosine kinase 2 inhibitor | 0.101 0.007 DBMET03165 0.068 0.023 DBMET03167 0.06 0.031 DBMET03166 | DBMET03165 | |
| 0.015 | 0.682 | 0.151 | Antiamyloidogenic | 0.151 0.147 DBMET03165 | DBMET03165 | |
| 0.007 | 0.68 | 0.087 | Protein kinase C beta inhibitor | 0.087 0.022 DBMET03165 0.069 0.05 DBMET03167 0.068 0.051 DBMET03166 | DBMET03165 | |
| 0.002 | 0.686 | 0.061 | Vascular adhesion protein 1 inhibitor | 0.061 0.009 DBMET03165 0.054 0.013 DBMET03167 0.043 0.022 DBMET03166 | DBMET03165 | |
| 0.008 | 0.693 | 0.1 | Falcipain 3 inhibitor | 0.1 0.07 DBMET03166 | DBMET03166 | |
| 0.005 | 0.691 | 0.081 | Secretase beta inhibitor | 0.076 0.04 DBMET03165 0.081 0.035 DBMET03166 | DBMET03166 | |
| 0.038 | 0.726 | 0.23 | GABA C receptor rho-3 antagonist | 0.23 0.173 DBMET03165 | DBMET03165 | |
| 0.02 | 0.718 | 0.249 | Antiobesity | 0.245 0.161 DBMET03162 0.225 0.181 DBMET03165 0.249 0.158 DBMET03166 0.225 0.181 DBMET03168 | DBMET03166 | |
| 0.004 | 0.702 | 0.015 | Adenosine A2b receptor agonist | 0.015 0.009 DBMET03163 | DBMET03163 | |
| 0.006 | 0.716 | 0.053 | Cytokine production stimulant | 0.053 0.022 DBMET03165 | DBMET03165 | |
| 0.023 | 0.74 | 0.134 | Hexokinase inhibitor | 0.134 0.098 DBMET03166 | DBMET03166 | |
| 0.006 | 0.734 | 0.059 | Histone deacetylase SIRT3 inhibitor | 0.059 0.052 DBMET03166 | DBMET03166 | |
| 0.025 | 0.755 | 0.25 | Immunomodulator | 0.199 0.165 DBMET03161 0.25 0.115 DBMET03165 0.221 0.14 DBMET03169 0.2 0.165 DBMET03166 | DBMET03165 | |
| 0.013 | 0.746 | 0.153 | Hemostatic | 0.15 0.068 DBMET03165 0.153 0.064 DBMET03166 | DBMET03166 | |
| 0.06 | 0.81 | 0.121 | CC chemokine 6 receptor antagonist | 0.121 0.111 DBMET03169 | DBMET03169 | |
| 0.007 | 0.764 | 0.069 | Purinergic P2X2 antagonist | 0.069 0.046 DBMET03165 | DBMET03165 | |
| 0.003 | 0.762 | 0.075 | Alpha 2 adrenoreceptor agonist | 0.075 0.028 DBMET03165 | DBMET03165 | |
| 0.06 | 0.821 | 0.174 | 5 Hydroxytryptamine 3E antagonist | 0.174 0.124 DBMET03166 | DBMET03166 | |
| 0.003 | 0.77 | 0.077 | Alpha adrenoreceptor agonist | 0.077 0.04 DBMET03165 | DBMET03165 | |
| 0.009 | 0.777 | 0.09 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.09 0.049 DBMET03165 0.087 0.053 DBMET03166 | DBMET03165 | |
| 0.057 | 0.826 | 0.276 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.276 0.247 DBMET03166 | DBMET03166 | |
| 0.012 | 0.783 | 0.092 | MAP kinase kinase 7 inhibitor | 0.092 0.022 DBMET03165 0.079 0.048 DBMET03166 | DBMET03165 | |
| 0.007 | 0.781 | 0.078 | Myeloperoxidase inhibitor | 0.078 0.071 DBMET03165 | DBMET03165 | |
| 0.003 | 0.782 | 0.055 | Cyclin A1 inhibitor | 0.055 0.05 DBMET03165 0.055 0.05 DBMET03166 | DBMET03166 | |
| 0.022 | 0.81 | 0.424 | Antiinflammatory | 0.424 0.125 DBMET03165 0.317 0.2 DBMET03169 0.321 0.196 DBMET03166 | DBMET03165 | |
| 0.041 | 0.839 | 0.152 | MAP kinase kinase 5 inhibitor | 0.152 0.143 DBMET03165 | DBMET03165 | |
| 0.005 | 0.804 | 0.037 | Acetyl-CoA carboxylase inhibitor | 0.037 0.036 DBMET03168 | DBMET03168 | |
| 0.004 | 0.827 | 0.082 | Polo-like kinase-1 inhibitor | 0.082 0.079 DBMET03165 | DBMET03165 | |
| 0.028 | 0.869 | 0.146 | Death-associated protein kinase 2 inhibitor | 0.146 0.117 DBMET03166 | DBMET03166 | |
| 0.004 | 0.847 | 0.149 | MAP kinase kinase 1 inhibitor | 0.149 0.017 DBMET03165 0.094 0.064 DBMET03167 0.107 0.049 DBMET03166 | DBMET03165 | |
| 0.003 | 0.876 | 0.138 | LIM domain kinase 1 inhibitor | 0.138 0.11 DBMET03165 | DBMET03165 | |
| 0.008 | 0.881 | 0.116 | CDC-like kinase 3 inhibitor | 0.107 0.063 DBMET03165 0.116 0.049 DBMET03166 | DBMET03166 | |
| 0.004 | 0.878 | 0.095 | Protein kinase C theta inhibitor | 0.095 0.009 DBMET03165 0.085 0.012 DBMET03167 0.066 0.027 DBMET03166 | DBMET03165 | |
| 0.039 | 0.923 | 0.227 | MAP kinase kinase 3 inhibitor | 0.227 0.061 DBMET03165 | DBMET03165 | |
| 0.005 | 0.897 | 0.234 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.234 0.053 DBMET03165 0.205 0.073 DBMET03166 | DBMET03165 | |
| 0.003 | 0.91 | 0.113 | MAP kinase kinase inhibitor | 0.113 0.081 DBMET03165 | DBMET03165 | |
| 0.002 | 0.917 | 0.088 | Protein kinase C zeta inhibitor | 0.088 0.069 DBMET03165 | DBMET03165 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |